var title_f37_41_38544="Methoxsalen: Patient drug information";
var content_f37_41_38544=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"11\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Methoxsalen: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F12804671\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12804672\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?23/41/24212?source=see_link\">",
"       Methoxsalen (systemic): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/5/2132?source=see_link\">",
"       Methoxsalen (topical): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10857 Version 27.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-83C710A96E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38544=[""].join("\n");
var outline_f37_41_38544=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?23/41/24212?source=related_link\">",
"      Methoxsalen (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/5/2132?source=related_link\">",
"      Methoxsalen (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_41_38545="Ultrasound probes";
var content_f37_41_38545=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F59421&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F59421&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Variety of transducer options",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 430px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The center probe, a linear 12-5 mHz transducer, is most often used for peripheral vascular imaging. The left-hand probe, called a \"hockey stick\", can be useful in tight locations. The right-hand probe is a curved, lower frequency transducer that allows for greater tissue penetration in obese patients.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lauren W Averill, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38545=[""].join("\n");
var outline_f37_41_38545=null;
var title_f37_41_38546="Liver cyst 1";
var content_f37_41_38546=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F60766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F60766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Liver cyst 1",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 359px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38546=[""].join("\n");
var outline_f37_41_38546=null;
var title_f37_41_38547="Remifentanil: Patient drug information";
var content_f37_41_38547=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Remifentanil: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/50/5927?source=see_link\">",
"     see \"Remifentanil: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/56/31622?source=see_link\">",
"     see \"Remifentanil: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F217521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ultiva&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F217522\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ultiva&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10013067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put you to sleep for surgery.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10013066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702860",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to remifentanil or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10013070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10013071\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698261",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697975",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10013073\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699000",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Poor pain control.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10013069\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10013075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11420 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.16.9.173-D52E307D49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38547=[""].join("\n");
var outline_f37_41_38547=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217521\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217522\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013067\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013066\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013070\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013071\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013073\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013069\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013075\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?5/50/5927?source=related_link\">",
"      Remifentanil: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/56/31622?source=related_link\">",
"      Remifentanil: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_41_38548="Mafenide: Patient drug information";
var content_f37_41_38548=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Mafenide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/2/36899?source=see_link\">",
"     see \"Mafenide: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?10/28/10691?source=see_link\">",
"     see \"Mafenide: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F190673\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Sulfamylon&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691769",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat burns.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702427",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to mafenide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016251\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696699",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful if you have G6PD deficiency. Anemia may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697869",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fungal infection (rarely).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016249\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Cream:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694624",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean every day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear special gloves while putting this drug on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on as you have been told, 1 or 2 times a day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694411",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Always keep the burned part covered with cream.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695952",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The treated part may be covered with a dressing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705506",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Powder:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695430",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mix powder with sterile water or sodium chloride until it melts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put liquid on the gauze covering the burn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694464",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put liquid on every 4 to 8 hours or as you have been told by your doctor to keep the gauze wet.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699530",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store powder packets and cream at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699500",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid in a closed container.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699631",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any part of the opened liquid container not used after 48 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699632",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any part of the unopened liquid container not used after 28 days.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11204 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-6F4C19BDB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38548=[""].join("\n");
var outline_f37_41_38548=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190673\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016247\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016246\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016251\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016252\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016254\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016249\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016250\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016255\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016256\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?36/2/36899?source=related_link\">",
"      Mafenide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?10/28/10691?source=related_link\">",
"      Mafenide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_41_38549="Pathogenesis and pathophysiology of bacterial meningitis";
var content_f37_41_38549=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis and pathophysiology of bacterial meningitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38549/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38549/contributors\">",
"     Allan R Tunkel, MD, PhD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38549/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38549/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38549/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38549/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38549/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/41/38549/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;From its original recognition in 1805 until the early 1900s, bacterial meningitis was virtually 100 percent fatal. In 1913, Simon Flexner's introduction of intrathecal meningococcal antiserum prevented some deaths, but the clinical outcome did not dramatically improve until the advent of systemic antimicrobial therapy in the 1930s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the effectiveness of current antibiotics in clearing bacteria from the cerebrospinal fluid (CSF), bacterial meningitis continues to cause significant morbidity and mortality worldwide. In two large case series, for example, the case-fatality rate for adults with bacterial meningitis was approximately 25 percent, and transient or permanent neurologic morbidity occurred in 21 to 28 percent of survivors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/54/18280?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pathogenesis and pathophysiology of bacterial meningitis involve a complex interplay between virulence factors of the pathogens and the host immune response. Much of the damage from this infection is believed to result from cytokines released within the CSF as the host mounts an inflammatory response. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/54/18280?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinically important issues related to the pathogenesis and pathophysiology of bacterial meningitis will be reviewed here. The clinical features, treatment, prognosis, and prevention of bacterial meningitis in adults and children, and issues related to chronic and recurrent meningitis, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/17/22810?source=see_link\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/60/15306?source=see_link\">",
"     \"Treatment of bacterial meningitis caused by specific pathogens in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/8/28810?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38458?source=see_link\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/20/4424?source=see_link\">",
"     \"Approach to the patient with chronic meningitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/26/43433?source=see_link&amp;anchor=H26#H26\">",
"     \"Approach to the adult with recurrent infections\", section on 'Meningitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial meningitis develops when virulence factors of the pathogen overcome host defense mechanisms. For the most common pathogens causing bacterial meningitis in adults, such as Streptococcus pneumoniae and Neisseria meningitidis, meningeal invasion is related to several virulence factors that allow the bacteria to colonize host mucosal epithelium, invade and survive within the bloodstream, cross the blood-brain barrier, and multiply within the cerebrospinal fluid (CSF). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/32/7688?source=see_link\">",
"     \"Microbiology and pathobiology of Neisseria meningitidis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/50/27432?source=see_link\">",
"     \"Epidemiology of Neisseria meningitidis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Colonization and invasion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the major meningeal pathogens possess surface components, such as fimbriae or pili, that enhance mucosal colonization. Colonization of the host mucosal epithelium is facilitated by evasion of mucosal secretory IgA through pathogen secretion of IgA protease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/4\">",
"     4",
"    </a>",
"    ]. IgA protease inactivates the mucosal antibody and facilitates bacterial attachment to host epithelial cells. After successful colonization, invasion occurs across the epithelium via intracellular or intercellular pathways that are mediated by specific binding adhesins of the bacterial surface, many of which are localized to pili in gram-negative pathogens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/5\">",
"     5",
"    </a>",
"    ]. Surface encapsulation may also be an important virulence factor for nasopharyngeal colonization and systemic invasion of meningeal pathogens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Intravascular survival",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following invasion and entry into the bloodstream, bacteria survive through evasion of the complement system, particularly the alternative complement pathway. The bacterial capsular polysaccharide is the major mechanism for alternative complement evasion. As an example, the capsular sialic acid of N. meningitidis prevents binding of factor B to C3b and subsequent activation of the alternative pathway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/6\">",
"     6",
"    </a>",
"    ]. For S. pneumoniae, C3b binds inefficiently to factor B on the capsular surface [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/7\">",
"     7",
"    </a>",
"    ]. In either case, the pathogens avoid the bactericidal activity of complement, survive in the bloodstream, and cross the blood-brain barrier into the CSF.",
"   </p>",
"   <p>",
"    In contrast to these inhibitory effects on alternate pathway activity in the bloodstream, classical pathway complement activation may occur in the central nervous system and contribute to tissue injury in pneumococcal meningitis. This was suggested by studies in animal models of pneumococcal meningitis in which the administration of a C1-inhibitor, which inhibits the early phase of the classic complement pathway, was associated with increased bacterial clearance, reduced clinical illness, a less intense meningeal inflammatory infiltrate, and lower brain levels of proinflammatory cytokines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Meningeal invasion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The precise topographic site of bacterial entry into the CSF is unclear and may be distinct for different pathogens. For some pathogens such as Escherichia coli, experimental evidence suggests that CSF entry occurs at the choroid plexus and is facilitated by the presence of S fimbriae on the bacterial surface [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/9\">",
"     9",
"    </a>",
"    ]. By contrast, the phosphorylcholine moiety of the pneumococcal cell wall lipoteichoic acid appears to utilize endogenous receptors for platelet activating factor (PAF) to facilitate attachment and transcellular migration across endothelium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Upon successful invasion of the CSF, bacteria can multiply to high concentrations (eg, up to 10",
"    <sup>",
"     7",
"    </sup>",
"    organisms per milliliter) because of inadequate humoral immunity in the CSF. Specifically, low concentrations of immunoglobulin and complement within human CSF result in poor opsonic activity, successful bacterial replication, and the subsequent development of inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/11\">",
"     11",
"    </a>",
"    ]. Despite an early influx of leukocytes in bacterial meningitis, host defenses in CSF remain suboptimal because of the lack of functional opsonic and bactericidal activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical disease observed when bacteria enter the CSF is a result of a complex interaction of components of the bacteria and the host inflammatory response. This interaction influences both the blood-brain barrier and neuronal integrity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Contribution of cell wall components",
"    </span>",
"    &nbsp;&mdash;&nbsp;In experimental animal models, subcapsular bacterial surface components are most important for the induction of CSF inflammation and blood-brain barrier injury. As an example, purified pneumococcal cell wall, but not purified capsular polysaccharide, induced CSF inflammation similar to live pneumococci when experimentally injected into the cisterna magna of rabbits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/12\">",
"     12",
"    </a>",
"    ]. Both teichoic acid and peptidoglycan, which are cell wall constituents, were able to provoke this inflammatory response although the kinetics of the response differed (maximal response to teichoic acid at 5 hours and to peptidoglycan between 5 and 24 hours) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similarly, intracisternal inoculation of lipooligosaccharide of Neisseria meningitidis or lipopolysaccharide of Haemophilus influenzae can induce CSF inflammation and blood-brain barrier injury in a dose- and time-dependent fashion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Generation of inflammatory cytokines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some studies suggest that the mechanism by which these meningeal pathogens induce an inflammatory response and blood-brain barrier injury is through the in situ generation of inflammatory cytokines (eg, interleukin-1, interleukin-6, and tumor necrosis factor-alpha) and matrix metalloproteinases within the CSF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. High bacterial density and bacterial breakdown products that may also be generated after treatment with bacteriolytic antibiotics promote higher concentrations of inflammatory mediators, which lead to a higher likelihood of neurologic sequelae and severe disease. These cytokines act in conjunction with bacterial surface components, such as lipopolysaccharides, to induce the synthesis of adhesive glycoproteins on the luminal surface of cerebral endothelium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/15,17\">",
"     15,17",
"    </a>",
"    ]. These adhesive glycoproteins such as selectins and intercellular adhesion molecule (ICAM)-1, facilitate localized adhesion and diapedesis of neutrophils into the CSF. Some experimental evidence suggests that use of nonbacteriolytic antibiotics, which reduce the proinflammatory response triggered by cell-wall components, prevents neuronal damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/18\">",
"     18",
"    </a>",
"    ], although more studies are needed.",
"   </p>",
"   <p>",
"    Once inflammation is initiated, a series of injuries occur to the endothelium of the blood-brain barrier (eg, separation of intercellular tight junctions) that result in vasogenic brain edema, loss of cerebrovascular autoregulation, and increased intracranial pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. This results in localized areas of brain ischemia, cytotoxic injury, and neuronal apoptosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/22\">",
"     22",
"    </a>",
"    ]. Evidence also suggests that reactive nitrogen intermediates, nitric oxide, peroxynitrite (a powerful oxidative agent), and excitatory amino acids may also play important roles in either the inflammatory process or other pathophysiologic events (including neuronal injury) during bacterial meningitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38549/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. The clinical expressions of these pathophysiologic events are the neurologic complications of meningitis including coma, seizures, deafness, and motor, sensory, and cognitive deficits. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/54/18280?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20298351\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pathogenesis and pathophysiology of bacterial meningitis involve a complex interplay between virulence factors of the pathogens and the host immune response. Much of the damage from this infection is believed to result from cytokines released within the CSF as the host mounts an inflammatory response. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bacterial meningitis develops when virulence factors of the pathogen overcome host defense mechanisms. For the most common pathogens causing bacterial meningitis in adults, such as Streptococcus pneumoniae and Neisseria meningitidis, meningeal invasion is related to several virulence factors that allow the bacteria to colonize host mucosal epithelium, invade and survive within the bloodstream, cross the blood-brain barrier, and multiply within the cerebrospinal fluid (CSF). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In experimental animal models, subcapsular bacterial surface components are most important for the induction of CSF inflammation and blood-brain barrier injury. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Contribution of cell wall components'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some studies suggest that the mechanism by which these meningeal pathogens induce an inflammatory response and blood-brain barrier injury is through the in situ generation of inflammatory cytokines (eg, interleukin-1, interleukin-6, and tumor necrosis factor-alpha) and matrix metalloproteinases within the CSF. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Generation of inflammatory cytokines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once inflammation is initiated, a series of injuries occur to the endothelium of the blood-brain barrier (eg, separation of intercellular tight junctions) that result in vasogenic brain edema, loss of cerebrovascular autoregulation, and increased intracranial pressure. This results in localized areas of brain ischemia, cytotoxic injury, and neuronal apoptosis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Generation of inflammatory cytokines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evidence also suggests that reactive nitrogen intermediates, nitric oxide, peroxynitrite (a powerful oxidative agent), and excitatory amino acids may also play important roles in either the inflammatory process or other pathophysiologic events (including neuronal injury) during bacterial meningitis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Generation of inflammatory cytokines'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/1\">",
"      Schwentker FF, Gelman S, Long PH. Landmark article April 24, 1937. The treatment of meningococcic meningitis with sulfanilamide. Preliminary report. By Francis F. Schwentker, Sidney Gelman, and Perrin H. Long. JAMA 1984; 251:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/2\">",
"      Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/3\">",
"      Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998; 129:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/4\">",
"      Plaut AG. The IgA1 proteases of pathogenic bacteria. Annu Rev Microbiol 1983; 37:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/5\">",
"      Stephens DS, Farley MM. Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae. Rev Infect Dis 1991; 13:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/6\">",
"      Joiner KA. Complement evasion by bacteria and parasites. Annu Rev Microbiol 1988; 42:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/7\">",
"      Brown EJ, Joiner KA, Gaither TA, et al. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system. J Immunol 1983; 131:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/8\">",
"      Zwijnenburg PJ, van der Poll T, Florquin S, et al. C1 inhibitor treatment improves host defense in pneumococcal meningitis in rats and mice. J Infect Dis 2007; 196:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/9\">",
"      Parkkinen J, Korhonen TK, Pere A, et al. Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest 1988; 81:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/10\">",
"      Cundell DR, Gerard C, Idanpaan-Heikkila I, et al. PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells. Adv Exp Med Biol 1996; 416:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/11\">",
"      Simberkoff MS, Moldover NH, Rahal J Jr. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency. J Lab Clin Med 1980; 95:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/12\">",
"      Tuomanen E, Tomasz A, Hengstler B, Zak O. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis 1985; 151:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/13\">",
"      Tuomanen E, Liu H, Hengstler B, et al. The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 1985; 151:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/14\">",
"      Wispelwey B, Lesse AJ, Hansen EJ, Scheld WM. Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest 1988; 82:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/15\">",
"      Moser R, Schleiffenbaum B, Groscurth P, Fehr J. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 1989; 83:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/16\">",
"      Quagliarello VJ, Wispelwey B, Long WJ Jr, Scheld WM. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 1991; 87:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/17\">",
"      Quagliarello V, Scheld WM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 1992; 327:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/18\">",
"      Grandgirard D, Sch&uuml;rch C, Cottagnoud P, Leib SL. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis. Antimicrob Agents Chemother 2007; 51:2173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/19\">",
"      Quagliarello VJ, Long WJ, Scheld WM. Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation. J Clin Invest 1986; 77:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/20\">",
"      Quagliarello VJ, Ma A, Stukenbrok H, Palade GE. Ultrastructural localization of albumin transport across the cerebral microvasculature during experimental meningitis in the rat. J Exp Med 1991; 174:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/21\">",
"      Tureen JH, Dworkin RJ, Kennedy SL, et al. Loss of cerebrovascular autoregulation in experimental meningitis in rabbits. J Clin Invest 1990; 85:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/22\">",
"      Braun JS, Novak R, Herzog KH, et al. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 1999; 5:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/23\">",
"      Kastenbauer S, Koedel U, Becker BF, Pfister HW. Oxidative stress in bacterial meningitis in humans. Neurology 2002; 58:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38549/abstract/24\">",
"      Nau R, Br&uuml;ck W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 2002; 25:38.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1289 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.247-661AF214C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38549=[""].join("\n");
var outline_f37_41_38549=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20298351\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Colonization and invasion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Intravascular survival",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Meningeal invasion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Contribution of cell wall components",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Generation of inflammatory cytokines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20298351\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/26/43433?source=related_link\">",
"      Approach to the adult with recurrent infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/20/4424?source=related_link\">",
"      Approach to the patient with chronic meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/8/28810?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/50/27432?source=related_link\">",
"      Epidemiology of Neisseria meningitidis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/17/22810?source=related_link\">",
"      Initial therapy and prognosis of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/32/7688?source=related_link\">",
"      Microbiology and pathobiology of Neisseria meningitidis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/54/18280?source=related_link\">",
"      Neurologic complications of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38458?source=related_link\">",
"      Treatment and prognosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/60/15306?source=related_link\">",
"      Treatment of bacterial meningitis caused by specific pathogens in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_41_38550="TDE LV dyssynchrony";
var content_f37_41_38550=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tissue Doppler echocardiography color-coded images and time-velocity curves demonstrating dyssynchrony in a heart failure patient with left bundle branch block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 397px; height: 475px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The vertical yellow lines mark the ejection interval and the color-coded curves correspond to the 12 segments. The white arrows indicate the opposing wall delay in time-to-peak velocity from different left ventricular walls.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John Gorcsan III, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38550=[""].join("\n");
var outline_f37_41_38550=null;
var title_f37_41_38551="Evaluation of the HIV-infected patient with diarrhea";
var content_f37_41_38551=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of the HIV-infected patient with diarrhea",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38551/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38551/contributors\">",
"     C Mel Wilcox, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38551/contributors\">",
"     Christine A Wanke, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38551/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38551/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38551/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38551/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/41/38551/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diarrhea can cause significant morbidity in HIV-infected patients and can be due to a multitude of etiologies from infectious pathogens to malignancy to medications. Diarrhea is also an independent predictor of reduced quality of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The approach to the evaluation of chronic diarrhea will be discussed here. For detailed information about specific pathogens, please see appropriate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/62/22504?source=see_link\">",
"     \"AIDS-related cytomegalovirus gastrointestinal disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/55/38777?source=see_link\">",
"     \"Mycobacterium avium complex (MAC) infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the use of highly active antiretroviral therapy (HAART) in the United States, chronic diarrhea (defined as 28 days of diarrhea) was responsible for 17 percent of the new acquired immunodeficiency syndrome (AIDS) diagnoses reported to the Centers for Disease Control and Prevention (CDC) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the developing world, HAART is not routinely available for HIV-infected individuals, and diarrheal disease remains highly endemic even for those without HIV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/3\">",
"     3",
"    </a>",
"    ]. Chronic diarrheal disease in adults in Africa has been used as a predictor of HIV-seropositivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/4\">",
"     4",
"    </a>",
"    ]. HIV-infected children are more likely to die with diarrhea than children with diarrhea who are not infected with HIV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, in resource-rich nations where HAART is widely available, the incidence of infectious causes of diarrhea in HIV-infected patients with low CD4 counts (&lt;200",
"    <span class=\"nowrap\">",
"     cells/mm3)",
"    </span>",
"    has declined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/6\">",
"     6",
"    </a>",
"    ]. Experience at a single center between 1995 and 1997 found that, while the incidence of diarrhea remained constant, infectious etiologies declined from 53 to 13 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, despite HAART, 40 percent of HIV-infected adults still reported at least one episode of diarrhea in the preceding month in one longitudinal cohort of 600 patients in the Boston area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/8\">",
"     8",
"    </a>",
"    ]. Chronic diarrhea, defined as diarrhea persisting for more than four weeks, was reported in 28 percent of this cohort and severe diarrhea, defined as more than six stools per day, in 3 percent. The use of HAART itself (particularly",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/62/19433?source=see_link\">",
"     nelfinavir",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    ) can also lead to medication-induced diarrhea and is a leading diagnostic consideration when diarrhea is the sole complaint [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/9\">",
"     9",
"    </a>",
"    ]. When an infectious etiology is not ascertained, then HIV associated enteropathy needs to be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diarrheal disease in HIV-infected individuals is frequently caused by infectious agents but may also be due to infiltrative diseases, such as lymphoma or Kaposi's sarcoma (KS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The infectious pathogens associated with diarrheal disease in HIV infection may vary with the degree of immunocompromise in the host [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/10\">",
"     10",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef81945 \" href=\"mobipreview.htm?41/7/42107\">",
"     table 1",
"    </a>",
"    ). Routine enteric pathogens with sufficient virulence to cause disease in healthy hosts will cause diarrheal disease in HIV-infected individuals with intact or compromised immunologic function. Less virulent pathogens, which appear to require some immune compromise to establish disease, are more common in patients with more advanced HIV or AIDS. As an example, the enteroaggregative Escherichia coli (EAEC) that are associated with persistent diarrheal disease in children in the developing world but have limited potential to cause diarrhea in volunteers, have been associated with persistent diarrhea in HIV-infected adults in the United States and Switzerland [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37960?source=see_link\">",
"     \"Pathogenic Escherichia coli\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pathogens such as Cryptosporidium parvum, which can cause severe diarrheal disease in both immunocompetent and immunocompromised individuals, will become persistent in AIDS patients with CD4 counts &lt;180",
"    <span class=\"nowrap\">",
"     cells/mm3",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/16\">",
"     16",
"    </a>",
"    ]. By contrast, HIV-infected patients with a more preserved CD4 count usually have a self-limited illness with this organism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/40/13961?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The microsporidial organisms, Enterocytozoon bieneusi and Encephalitozoon intestinalis, are rare causes of diarrhea in immunocompetent hosts but have been associated with severe malabsorption and persistent diarrhea in HIV-infected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/3,8,17\">",
"     3,8,17",
"    </a>",
"    ]. Rarely, intestinal spirochetosis due to Brachyspira pilosicoli has been described in HIV-infected patients with abdominal pain, rectal discharge and bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/45/16089?source=see_link\">",
"     \"Microsporidiosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While organisms like Mycobacterium avium complex (MAC) are associated with lung infections in immunocompetent patients with chronic lung disease, they will also produce disseminated disease with bowel infiltration and malabsorption in patients with severe immune compromise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/11/24759?source=see_link\">",
"     \"Overview of nontuberculous mycobacterial infections in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/55/38777?source=see_link\">",
"     \"Mycobacterium avium complex (MAC) infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HIV infection of the gastrointestinal tract is also well documented. HIV infection may play a role in the pathogenesis of diarrhea and gastrointestinal illness, although it is not clear if the mechanism is direct infection of the enterocyte or infection of the lymphoid tissue of the gastrointestinal tract with dysregulation of local cytokine production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of symptoms, frequency and characteristics of stool, amount and pace of weight loss, and other abdominal or constitutional symptoms should be sought and will assist in placing a patient in the category of having small or large bowel diarrhea.",
"   </p>",
"   <p>",
"    Medication history and recent changes in medications, status of HIV disease, route of acquisition of HIV disease and other opportunistic illnesses or co-morbid illnesses should be ascertained. Since HIV is currently better suppressed by antiretroviral agents, more HIV-infected patients are presenting with non-HIV related co-morbid conditions. Thus, it is important to ask about a family history of inflammatory bowel disease that might lead to alternative diagnoses for diarrheal symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Regional involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;A careful history can assist in pinpointing the portion of the gastrointestinal tract most severely involved since certain infections have a propensity to involve particular regions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Small bowel involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The small bowel is an organ that has secretory and nutrient-absorbing functions. Disease that is predominantly located in the small bowel is likely to have a presentation that reflects the dysregulation of these two functions. Small bowel diarrhea is usually watery and of large volume; it may be associated with small bowel symptoms such as bloating, gas, cramping, and potentially profound weight loss. Some patients with involvement of the terminal ileum may present with malabsorption of D-xylose or vitamin B12&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/21\">",
"     21",
"    </a>",
"    ]. Patients with documented evidence of small bowel dysfunction are more likely to have a small bowel pathogen isolated from their stool [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Large bowel involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The large bowel is a storage organ where some additional absorption of water occurs. Thus, large bowel diarrhea is characterized by frequent, small volume, often painful stools. The pain associated with these illnesses is not related to the region of the gut but to the type of pathogens that cause disease in the colon. Malabsorption of nutrients does not occur in a diarrhea that is limited to the large bowel. Nutritional compromise does not occur in patients who have infection confined to the large bowel, unless the pathogen is also capable of causing a disseminated infection, a \"typhoidal\" presentation. In HIV-infected patients, the typhoidal syndrome may be caused by Salmonella or by disseminated infection due to a range of organisms including cytomegalovirus (CMV), MAC, M. tuberculosis or fungi, such as Histoplasma or Cryptococcus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/62/22504?source=see_link\">",
"     \"AIDS-related cytomegalovirus gastrointestinal disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/55/38777?source=see_link\">",
"     \"Mycobacterium avium complex (MAC) infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Anorectal involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a history of unprotected receptive anal intercourse prior to the development of severe tenesmus, dyschezia and urgency, localizes the process to the anorectum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is also important to ascertain the nature and chronicity of symptoms as well as the most recent CD4 cell count, which will directly impact on diagnostic considerations. As noted above, patients with CD4 cell counts &lt;100",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    are at risk for opportunistic infections which are typically chronic, such as Cryptosporidium, MAC, CMV, Isospora, or Microsporidium.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Upper or mid-abdominal cramps, bloating, and nausea suggest gastric or small bowel involvement, or both, which would be more common in MAC, Cryptosporidium, Giardia, or Isospora belli infections.",
"     </li>",
"     <li>",
"      Severe watery diarrhea resulting in dehydration, electrolyte disturbances, and weight loss, suggests intestinal cryptosporidiosis.",
"     </li>",
"     <li>",
"      Hematochezia, tenesmus, and lower abdominal cramps usually imply colonic infection caused by opportunistic pathogens such as CMV, or less commonly HSV, or bacterial infections, such as Salmonella, Yersinia, Shigella or Campylobacter. If the patient is severely immunocompromised, these bacterial infections can follow a severe, chronic, or relapsing clinical course in association with extraintestinal symptoms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/23\">",
"       23",
"      </a>",
"      ]. Lower gastrointestinal bleeding has been uncommonly associated with Kaposi's sarcoma and Bartonella infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/24\">",
"       24",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/37/18009?source=see_link\">",
"       \"AIDS-related Kaposi sarcoma: Staging and treatment\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/63/8182?source=see_link\">",
"       \"Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Weight loss accompanying chronic diarrhea may suggest an opportunistic infection, infiltrative disease, or presence of malabsorption or small bowel overgrowth syndrome. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42584?source=see_link\">",
"       \"Management of tissue wasting in patients with HIV infection\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Exposures",
"    </span>",
"    &nbsp;&mdash;&nbsp;An epidemiologic history concentrating on exposures should be ascertained:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient should be interviewed about travel history (Entamoeba, Giardia), sexual exposures, food associations (lactose intolerance) or other significant past medical history (eg, chronic pancreatitis) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/25,26\">",
"       25,26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A history of unprotected receptive anal intercourse may suggest sexual transmission of Herpes simplex virus (HSV), Neisseria gonorrhea, Chlamydia, or occasionally Entamoebae [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In patients who are taking HAART, medication-induced diarrhea should be strongly considered, particularly when diarrhea is the sole presenting symptom [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/28\">",
"       28",
"      </a>",
"      ]. Agents commonly associated with frequent diarrhea include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/62/19433?source=see_link\">",
"       nelfinavir",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"       ritonavir",
"      </a>",
"      ; other implicated agents include mainly protease inhibitors (ie, lopinavir,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/11/44217?source=see_link\">",
"       fosamprenavir",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/31/506?source=see_link\">",
"       atazanavir",
"      </a>",
"      ). Diarrhea associated with bloating, nausea, and mild abdominal pain may be related to mitochondrial toxicity of chronic nucleoside analogue therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Clostridium difficile is an important diagnostic consideration in the HIV-infected patient who has had recent exposure to antibiotics. &nbsp;In a retrospective study of more than 11,000 episodes of diarrheal illness among HIV-infected patients, C. difficile was the most commonly identified pathogen, accounting for 54 percent of all bacterial agents [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/30\">",
"       30",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"     <li>",
"      Prior exposure to antibiotics can uncommonly cause small bowel overgrowth syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A careful physical examination is necessary to help determine the degree of wasting or any particular findings that may point to specific diseases.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Height and weight will assist in determining nutritional status.",
"     </li>",
"     <li>",
"      Orthostatic blood pressure will determine the degree of volume depletion, both suggesting infection of the small bowel.",
"     </li>",
"     <li>",
"      The skin and mucous membranes may reflect underlying micronutrient deficiencies, which could also accompany a small bowel process.",
"     </li>",
"     <li>",
"      Fever in an immunosuppressed host may indicate the possibility of opportunistic infections such as CMV, MAC, and other pathogens.",
"     </li>",
"     <li>",
"      Hepatosplenomegaly may suggest a systemic infiltrative process, such as MAC, histoplasmosis, or lymphoma.",
"     </li>",
"     <li>",
"      Abdominal tenderness may indicate the possibility of an abdominal abscess, colitis, or biliary tract or pancreatic disease.",
"     </li>",
"     <li>",
"      Perirectal tenderness may suggest anorectal infection from gonorrhea or Chlamydia or lymphogranuloma venereum.",
"     </li>",
"     <li>",
"      Guaiac positive stools in a patient with advanced immunosuppression may suggest mucosal disease such as CMV or HSV colitis.",
"     </li>",
"     <li>",
"      A full physical examination, including ophthalmologic evaluation in the patient with advanced immunosuppression, is important since there may be other clues as to the etiology of diarrhea, such as concomitant retinitis and colitis from CMV infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     LABORATORY TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory tests beyond routine studies should depend upon the severity of illness and leads from the history and physical examination. Tests such as albumin, or micronutrient levels may be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 50 percent of diarrheal illnesses in HIV-infected individuals may have no readily identifiable pathogen; this number can be reduced somewhat if a comprehensive diagnostic workup is undertaken [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/10,22\">",
"     10,22",
"    </a>",
"    ]. The goal of an extensive evaluation is to identify any treatable cause of diarrheal disease.",
"   </p>",
"   <p>",
"    The first approach should be stool examination and cultures; a thorough evaluation with multiple specimens (including three samples for ova and parasites), will hopefully obviate any need for more invasive testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Stool examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stool examinations should be ordered for culture of bacteria, C. difficile toxin assay, and examination for ova and parasites (",
"    <a class=\"graphic graphic_table graphicRef58409 \" href=\"mobipreview.htm?11/16/11533\">",
"     table 2",
"    </a>",
"    ). An acid-fast smear should also be requested to look for Cryptosporidium, Isospora, and Cyclospora. In patients with CD4 counts &lt;100",
"    <span class=\"nowrap\">",
"     cells/microL,",
"    </span>",
"    the possibility of Microsporidium should also be investigated via trichrome staining of a stool specimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Blood cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;If disseminated MAC infection is a diagnostic consideration, blood should also be obtained in fungal isolator tubes for culture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with advanced immunocompromise and either persistent diarrhea or diarrhea with fever, more extensive workup is reasonable, with small bowel biopsies looking for MAC, lymphoma, or microsporidiosis. In patients with colitis and negative stool examinations, colonoscopy and biopsy looking for CMV or other inflammatory enteridites should be considered. A history of guaiac positive stools in the setting of weight loss may be a presenting symptom of Kaposi's sarcoma, which can be seen as vascular mucosal lesions on endoscopy. Skin lesions are usually present with disseminated Kaposi's sarcoma.",
"   </p>",
"   <p>",
"    In the patient with suspected colitis, if a diagnosis is not made with careful stool analysis, we recommend sigmoidoscopy with biopsy as the next procedure. Biopsies should be preferentially taken of any abnormal appearing mucosa. While colonoscopy, rather than sigmoidoscopy, has been advocated for enhanced diagnosis of CMV confined to the right colon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/32,33\">",
"     32,33",
"    </a>",
"    ], we recommend reserving this procedure for patients in whom the sigmoidoscopy is negative as a more cost-effective approach.",
"   </p>",
"   <p>",
"    This recommendation is supported by a prospective study of 79 patients with HIV-related diarrhea who underwent evaluation with stool studies, upper endoscopy, and colonoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/34\">",
"     34",
"    </a>",
"    ]. Of these patients, endoscopic evaluation provided a new diagnosis in 22 patients (28 percent). Biopsies of the sigmoid colon alone were sufficient to establish the diagnosis of CMV in all 15 patients. The majority of patients with a positive terminal ileal biopsy had microsporidiosis, which could have also been diagnosed by a modified trichrome stain of stool [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/35\">",
"     35",
"    </a>",
"    ]. Another study from Taiwan confirmed the value of endoscopy after two weeks of failed symptomatic therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If lower tract evaluation is negative, upper endoscopy can occasionally uncover proximal small bowel infection by Cryptosporidium, Microsporidium, histoplasmosis or MAC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/32,37\">",
"     32,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The decision to perform upper or lower endoscopy first is suggested by the symptom complex. Classic features of colitis (cramps, fecal leukocytes, bloody stool",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fever) suggests lower endoscopy will have the highest yield. Symptoms suggesting enteritis (watery high volume diarrhea without fever or fecal leukocytes) would suggest proceeding with upper endoscopy as the initial test. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Regional involvement'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographic contrast studies generally are not useful in evaluating diarrhea in these patients since most disorders require mucosal biopsy. CT scan may show evidence of:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Colitis (CMV, HSV, Clostridium difficile)",
"     </li>",
"     <li>",
"      Abdominal adenopathy or hepatosplenomegaly (MAC, tuberculosis, histoplasmosis, lymphoma)",
"     </li>",
"     <li>",
"      Biliary tract disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malnutrition can be a serious complication of diarrheal disease in HIV-infected patients, since malabsorption of nutrients may accompany diarrhea and people with diarrhea may minimize intake because of intestinal symptoms or to control the frequency of stooling. Malnutrition remains a strong predictor of morbidity and mortality in those infected with HIV.",
"   </p>",
"   <p>",
"    Significant electrolyte disturbances can also occur, particularly in the setting of severe cryptosporidiosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     EMPIRIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;If stool evaluation and flexible sigmoidoscopy are nondiagnostic, some clinicians prefer empiric antibiotic therapy with a quinolone and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    to treat possible small bowel overgrowth, culture-negative Campylobacter, or Giardia. However, small bowel overgrowth as a cause of diarrhea is very rare. In addition, antibiotics may lead to additional adverse events. We generally do not recommend this strategy unless the patient has a clinical history strongly suggestive of a possible diagnosis (ie, the sexual partner was recently diagnosed with Giardia). Empiric therapy directed towards amebic colitis is also",
"    <strong>",
"     not",
"    </strong>",
"    recommended in developed countries.",
"   </p>",
"   <p>",
"    If a particular antiretroviral medication is the culprit (ie,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    ), alternative medications should be substituted, whenever possible. If chronic diarrhea continues unabated without a diagnosis, symptomatic therapy with an antimotility drug (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/53/16214?source=see_link\">",
"     loperamide",
"    </a>",
"    or diphenoxylate with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    [Lomotil]) can be initiated. An alternative to an antimotility agent is",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/56/21379?source=see_link\">",
"     crofelemer",
"    </a>",
"    , a botanical agent that blocks chloride secretion and accompanying high-volume water loss in diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/38\">",
"     38",
"    </a>",
"    ]. Crofelemer was approved by the US Food and Drug Administration in 2012 for noninfectious diarrhea in HIV-infected patients receiving antiretroviral therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/39\">",
"     39",
"    </a>",
"    ]. The safety and efficacy of crofelemer were evaluated in a trial of 374 HIV-infected patients with noninfectious diarrhea; 17.6 percent of patients receiving crofelemer experienced clinical response compared with 8 percent of patients receiving placebo. The dosage of crofelemer is 125 mg orally twice daily. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/17/32025?source=see_link&amp;anchor=H21#H21\">",
"     \"Approach to the adult with acute diarrhea in developed countries\", section on 'Symptomatic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Attention should also be given to nutritional support during the time of diagnostic evaluation if needed. There are few data on the use of antimotility agents for chronic diarrhea in patients with AIDS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Zinc deficiency, which is commonly found in HIV-infected patients, has been associated with pathogen negative diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/21\">",
"     21",
"    </a>",
"    ]. However, a randomized controlled trial of dietary zinc supplementation had no significant effect on the duration or remission of diarrhea in HIV-infected adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38551/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Expectant observation is probably appropriate in the patient with acute small bowel, watery diarrhea and a CD4 count that approaches normal, since these syndromes are likely to be self-limited and relatively benign. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/17/32025?source=see_link\">",
"     \"Approach to the adult with acute diarrhea in developed countries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12120099\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diarrhea can cause significant morbidity in HIV-infected patients and may be due to a multitude of etiologies, including infection, malignancy, or medications. Diarrhea is also an independent predictor of reduced quality of life. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prior to the use of highly active antiretroviral therapy in the United States, chronic diarrhea was responsible for a significant proportion of AIDS-defining conditions. However, the incidence of infectious causes of diarrhea in HIV-infected patients with low CD4 counts (&lt;200",
"      <span class=\"nowrap\">",
"       cells/mm3)",
"      </span>",
"      has declined. Chronic diarrhea remains an important source of morbidity in resource-limited settings where antiretroviral therapy is not available. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Incidence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diarrheal disease in HIV-infected individuals is frequently caused by infectious agents but may also be due to infiltrative diseases, such as lymphoma or Kaposi's sarcoma. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A detailed history should include the duration of symptoms, frequency and characteristics of stool, amount and pace of weight loss, and other abdominal or constitutional symptoms. Current medications should be reviewed. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who are taking antiretroviral therapy, medication-induced diarrhea should be strongly considered, particularly when diarrhea is the sole presenting symptom. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A careful physical examination is necessary to help determine the degree of wasting or any particular findings that may point to specific diseases. For example, fever and wasting may suggest an underlying opportunistic infection. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Helpful diagnostic studies include stool and blood cultures. Endoscopy and CT imaging may be required if the initial noninvasive workup is nondiagnostic. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnostic studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of severe diarrhea include weight loss, malnutrition, and electrolyte disturbance. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If chronic diarrhea continues unabated without a diagnosis, symptomatic therapy with an antimotility drug can be initiated. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Empiric therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/1\">",
"      Siddiqui U, Bini EJ, Chandarana K, et al. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy. J Clin Gastroenterol 2007; 41:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/2\">",
"      Bartlett JG, Belitsos PC, Sears CL. AIDS enteropathy. Clin Infect Dis 1992; 15:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/3\">",
"      Wanke CA, Cohan D, Thummakul T, et al. Diarrheal disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. Am J Trop Med Hyg 1999; 60:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/4\">",
"      Colebunders R, Francis H, Mann JM, et al. Persistent diarrhea, strongly associated with HIV infection in Kinshasa, Zaire. Am J Gastroenterol 1987; 82:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/5\">",
"      Thea DM, St Louis ME, Atido U, et al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants. N Engl J Med 1993; 329:1696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/6\">",
"      Ledergerber B, Egger M, Erard V, et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA 1999; 282:2220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/7\">",
"      Call SA, Heudebert G, Saag M, Wilcox CM. The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3. Am J Gastroenterol 2000; 95:3142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/8\">",
"      Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol 2000; 95:3482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/9\">",
"      Reijers MH, Weigel HM, Hart AA, et al. Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study. AIDS 2000; 14:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/10\">",
"      Mayer HB, Wanke CA. Diagnostic strategies in HIV-infected patients with diarrhea. AIDS 1994; 8:1639.",
"     </a>",
"    </li>",
"    <li>",
"     Wanke CA. Gastrointestinal infections in AIDS. In: Infectious Disease Teaching Atlas, 2nd ed, Mildvan D, Mandell GL (Eds), Churchill Livingstone, Philadelphia 1997. p.9.2-9.8.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/12\">",
"      Weber R, Ledergerber B, Zbinden R, et al. Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study. Arch Intern Med 1999; 159:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/13\">",
"      Mayer HB, Wanke CA. Enteroaggregative Escherichia coli as a possible cause of diarrhea in an HIV-infected patient. N Engl J Med 1995; 332:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/14\">",
"      Wanke CA, Mayer H, Weber R, et al. Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus. J Infect Dis 1998; 178:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/15\">",
"      Durrer P, Zbinden R, Fleisch F, et al. Intestinal infection due to enteroaggregative Escherichia coli among human immunodeficiency virus-infected persons. J Infect Dis 2000; 182:1540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/16\">",
"      Flanigan T, Whalen C, Turner J, et al. Cryptosporidium infection and CD4 counts. Ann Intern Med 1992; 116:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/17\">",
"      Asmuth DM, DeGirolami PC, Federman M, et al. Clinical features of microsporidiosis in patients with AIDS. Clin Infect Dis 1994; 18:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/18\">",
"      Barakat SS, Campbell WN. Refractory diarrhea in a patient with HIV infection. Clin Infect Dis 2009; 48:213; 257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/19\">",
"      Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/20\">",
"      Asmuth DM, Hammer SM, Wanke CA. Physiological effects of HIV infection on human intestinal epithelial cells: an in vitro model for HIV enteropathy. AIDS 1994; 8:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/21\">",
"      Lambl BB, Federman M, Pleskow D, Wanke CA. Malabsorption and wasting in AIDS patients with microsporidia and pathogen-negative diarrhea. AIDS 1996; 10:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/22\">",
"      Connolly GM, Forbes A, Gazzard BG. Investigation of seemingly pathogen-negative diarrhoea in patients infected with HIV1. Gut 1990; 31:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/23\">",
"      Angulo FJ, Swerdlow DL. Bacterial enteric infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21 Suppl 1:S84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/24\">",
"      Koehler JE, Cederberg L. Intra-abdominal mass associated with gastrointestinal hemorrhage: a new manifestation of bacillary angiomatosis. Gastroenterology 1995; 109:2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/25\">",
"      Blanshard C, Collins C, Francis N, Gazzard BG. Invasive amoebic colitis in AIDS patients. AIDS 1992; 6:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/26\">",
"      Corazza GR, Ginaldi L, Furia N, et al. The impact of HIV infection on lactose absorptive capacity. J Infect 1997; 35:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/27\">",
"      Rabeneck L, Crane MM, Risser JM, et al. Effect of HIV transmission category and CD4 count on the occurrence of diarrhea in HIV-infected patients. Am J Gastroenterol 1993; 88:1720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/28\">",
"      Guest JL, Ruffin C, Tschampa JM, et al. Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir. Pharmacotherapy 2004; 24:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/29\">",
"      Brinkman K, Kakuda TN. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy? Curr Opin Infect Dis 2000; 13:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/30\">",
"      Sanchez TH, Brooks JT, Sullivan PS, et al. Bacterial diarrhea in persons with HIV infection, United States, 1992-2002. Clin Infect Dis 2005; 41:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/31\">",
"      Chioralia G, Trammer T, Kampen H, Seitz HM. Relevant criteria for detecting microsporidia in stool specimens. J Clin Microbiol 1998; 36:2279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/32\">",
"      Wilcox CM, Schwartz DA, Cotsonis G, Thompson SE 3rd. Chronic unexplained diarrhea in human immunodeficiency virus infection: determination of the best diagnostic approach. Gastroenterology 1996; 110:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/33\">",
"      Dieterich DT, Rahmin M. Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J Acquir Immune Defic Syndr 1991; 4 Suppl 1:S29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/34\">",
"      Kearney DJ, Steuerwald M, Koch J, Cello JP. A prospective study of endoscopy in HIV-associated diarrhea. Am J Gastroenterol 1999; 94:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/35\">",
"      Didier ES, Orenstein JM, Aldras A, et al. Comparison of three staining methods for detecting microsporidia in fluids. J Clin Microbiol 1995; 33:3138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/36\">",
"      Wei SC, Hung CC, Chen MY, et al. Endoscopy in acquired immunodeficiency syndrome patients with diarrhea and negative stool studies. Gastrointest Endosc 2000; 51:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/37\">",
"      Sharpstone D, Gazzard B. Gastrointestinal manifestations of HIV infection. Lancet 1996; 348:379.",
"     </a>",
"    </li>",
"    <li>",
"     Fulyzaq (crofelemer) prescribing information. file://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202292s000lbl.pdf (Accessed on January 14, 2013).",
"    </li>",
"    <li>",
"     US Food and Drug Administration. FDA News Release. FDA approves first anti-diarrheal drug for HIV/AIDS patients. file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333701.htm (Accessed on January 14, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/40\">",
"      Nwachukwu CE, Okebe JU. Antimotility agents for chronic diarrhoea in people with HIV/AIDS. Cochrane Database Syst Rev 2008; :CD005644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38551/abstract/41\">",
"      C&aacute;rcamo C, Hooton T, Weiss NS, et al. Randomized controlled trial of zinc supplementation for persistent diarrhea in adults with HIV-1 infection. J Acquir Immune Defic Syndr 2006; 43:197.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3728 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-2D9DC08A38-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38551=[""].join("\n");
var outline_f37_41_38551=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12120099\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Regional involvement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Small bowel involvement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Large bowel involvement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Anorectal involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Exposures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      LABORATORY TESTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIAGNOSTIC STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Stool examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Blood cultures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Endoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      EMPIRIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12120099\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3728\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3728|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/7/42107\" title=\"table 1\">",
"      Enteric pathogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/16/11533\" title=\"table 2\">",
"      Causes of diarrhea in AIDS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/37/18009?source=related_link\">",
"      AIDS-related Kaposi sarcoma: Staging and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/62/22504?source=related_link\">",
"      AIDS-related cytomegalovirus gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/17/32025?source=related_link\">",
"      Approach to the adult with acute diarrhea in developed countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/63/8182?source=related_link\">",
"      Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/40/13961?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42584?source=related_link\">",
"      Management of tissue wasting in patients with HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/45/16089?source=related_link\">",
"      Microsporidiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/55/38777?source=related_link\">",
"      Mycobacterium avium complex (MAC) infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/11/24759?source=related_link\">",
"      Overview of nontuberculous mycobacterial infections in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37960?source=related_link\">",
"      Pathogenic Escherichia coli",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_41_38552="Acute management of nephrolithiasis in children";
var content_f37_41_38552=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute management of nephrolithiasis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38552/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38552/contributors\">",
"     Thomas S Lendvay, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38552/contributors\">",
"     Jodi Smith, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38552/contributors\">",
"     F Bruder Stapleton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38552/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38552/contributors\">",
"     Laurence S Baskin, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38552/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38552/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/41/38552/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 27, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of pediatric nephrolithiasis is divided into two parts.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute episode &ndash; During the acute phase when the stone is being passed, management is directed towards pain control, and facilitating passage or removal of the stone(s).",
"     </li>",
"     <li>",
"      Prevention of recurrent disease &ndash; After the acute episode, management is directed towards prevention of recurrent stone disease. This includes an evaluation to identify any underlying cause or risk factors for stone formation. Based upon this assessment, interventions are tailored to reduce the risk of recurrent stone formation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The acute management of childhood nephrolithiasis will be reviewed here. The prevention of recurrent disease, epidemiology, risk factors, clinical manifestations, and diagnosis of nephrolithiasis in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/62/19432?source=see_link\">",
"     \"Prevention of recurrent nephrolithiasis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/60/6090?source=see_link\">",
"     \"Epidemiology of and risk factors for nephrolithiasis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/19/13623?source=see_link\">",
"     \"Clinical features and diagnosis of nephrolithiasis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The acute management of nephrolithiasis depends upon the severity of the pain, and the presence of obstruction or infection. In some patients, outpatient medical management with oral analgesics and hydration is possible. However, in others, especially those with nausea, vomiting, and severe pain, hospitalization is required for parenteral fluid and pain medication. Other indications for hospitalization include urinary obstruction, solitary kidney, and infection.",
"   </p>",
"   <p>",
"    Urologic removal of stones may be required in patients with unremitting severe pain that is refractory to analgesic therapy, or in those with obstruction or infection. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Indications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MEDICAL MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pain control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both nonsteroidal antiinflammatory drugs (NSAIDs) and opioid therapy are used to control pain associated with nephrolithiasis. In studies of adult patients, both classes of analgesics are effective in pain relief. Combination therapy of the two has also been reported to be effective and in some cases superior to either agent alone. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20266?source=see_link&amp;anchor=H19#H19\">",
"     \"Diagnosis and acute management of suspected nephrolithiasis in adults\", section on 'Pain control'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/29/31194?source=see_link&amp;anchor=H7977256#H7977256\">",
"     \"Pharmacologic agents for pediatric procedural sedation outside of the operating room\", section on 'Analgesic agents'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/3/25658?source=see_link&amp;anchor=H2253101#H2253101\">",
"     \"Selection of medications for pediatric procedural sedation outside of the operating room\", section on 'Analgesia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    At our institution, in patients with less severe disease who can be managed as an outpatient, we initiate pain relief with NSAIDs if renal function is not impaired. If pain relief is not achieved, the patient may require hospitalization for more aggressive therapy. In the hospitalized patient, we use hydration, intravenous",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/43/34480?source=see_link\">",
"     ketorolac",
"    </a>",
"    , and opioid therapy.",
"   </p>",
"   <p>",
"    The use of NSAIDs should be stopped three days before a urologic intervention, if possible, to minimize the risk of bleeding. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20266?source=see_link&amp;anchor=H19#H19\">",
"     \"Diagnosis and acute management of suspected nephrolithiasis in adults\", section on 'Pain control'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Urine culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because urinary tract infection (UTI) is often present in children with nephrolithiasis, a urine culture should be obtained. If a UTI is diagnosed, appropriate antibiotic therapy should be initiated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/60/6090?source=see_link&amp;anchor=H15#H15\">",
"     \"Epidemiology of and risk factors for nephrolithiasis in children\", section on 'Infection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=see_link&amp;anchor=H5#H5\">",
"     \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\", section on 'Antibiotic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Stone passage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of stones less than 5 mm in diameter will pass spontaneously, even in small children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Hydration increases urinary flow and is thought to facilitate stone passage.",
"   </p>",
"   <p>",
"    In adults, several medical interventions have been used to increase the passage rate of ureteral stones, including antispasmodic agents, calcium channel blockers, and alpha blockers. Data are limited on the use of these agents in children.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one small clinical trial of 39 patients, children with distal ureteral stones that were smaller than 10 mm were randomly assigned to either",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?26/63/27638?source=see_link\">",
"       doxazosin",
"      </a>",
"      (an alpha blocker) at a daily dose of about 0.03",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/48/7946?source=see_link\">",
"       ibuprofen",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/3\">",
"       3",
"      </a>",
"      ]. There were no differences between the doxazosin and ibuprofen groups in the rate of stone passage (84 versus 70 percent) or in the mean time for stone expulsion (5.9 versus 6.1 days).",
"     </li>",
"     <li>",
"      In contrast, another trial of 45 children (ages 3 to 15 years) reported increased expulsion rates for patients with distal ureteral stones who received both",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?26/63/27638?source=see_link\">",
"       doxazosin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/48/7946?source=see_link\">",
"       ibuprofen",
"      </a>",
"      compared with those who only received ibuprofen (71 versus 29 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/28/39365?source=see_link\">",
"       Tamsulosin",
"      </a>",
"      , an alpha blocker, was studied in a prospective controlled trial in 61 children with distal ureteral stones &lt;12 mm in diameter. In this small study, children who received tamsulosin and standard analgesia, compared with those treated with placebo and standard analgesia, had a higher stone-fee rate at the end of the four-week trial (88 versus 64 percent) and a shorter mean stone expulsion time (8.2 versus 14.5 days) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In our practice, we have used alpha blockers to facilitate stone passage in children with distal ureteral stones. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20266?source=see_link&amp;anchor=H22#H22\">",
"     \"Diagnosis and acute management of suspected nephrolithiasis in adults\", section on 'Facilitating stone passage'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In children, ultrasonography and a single kidney-ureter-bladder (KUB) radiograph (if the stone is radiopaque) are generally used to monitor stone passage because noncontrast helical computed tomography (CT) is more costly and is associated with higher radiation exposure. CT, however, is the most sensitive imaging modality in the detection of renal or urinary tract stones and is used in the diagnosis of nephrolithiasis, especially when true stone burden and exact stone location are required for surgical management. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/19/13623?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical features and diagnosis of nephrolithiasis in children\", section on 'Imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Stone retrieval",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     family/patient",
"    </span>",
"    should be instructed to strain the child's urine for several days, in order to retrieve the stone. If the stone or any fragment is recovered, it should be sent for stone analysis. The known composition of the stone can guide further evaluation and preventive measures to prevent recurrent stones.",
"   </p>",
"   <p>",
"    Urinary strainers are available from medical supply companies. If a urinary strainer cannot be obtained, a receptacle covered by a cheese cloth or fine mesh sheet can be used. A fish net used for home aquariums is also a good alternative. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/62/19432?source=see_link&amp;anchor=H4#H4\">",
"     \"Prevention of recurrent nephrolithiasis in children\", section on 'Evaluation for underlying risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     UROLOGIC INTERVENTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for urologic intervention are based upon observational evidence that is primarily from adult studies. Although similar data are not available for children, we believe this evidence is directly applicable to children with nephrolithiasis. In our practice, urologic intervention is performed versus continued observation with medical management in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unremitting severe pain &ndash; Severe pain despite adequate analgesia is most often due to a uretero-vesical (UVJ) or uretero-pelvic junction (UPJ) stone, which is usually accompanied by obstruction. In these patients, pain is relieved with a temporizing ureteral stent and subsequent stone removal, regardless of the size of the stone.",
"     </li>",
"     <li>",
"      Urinary obstruction &ndash; Obstruction from renal calculi can result in renal parenchymal injury and a decrease in renal function [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/6\">",
"       6",
"      </a>",
"      ]. Intervention in patients with mild renal insufficiency demonstrates both an initial improvement in renal function due to the relief of the obstruction and subsequent improvement thought to be due to recovery of injured renal tissue [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. Without relief, persistent obstruction can result in permanent scarring and loss of renal tissue [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nevertheless, because of the high spontaneous stone passage rates for smaller calculi, as well as the cost and potential complications from urologic procedures, it is generally accepted that an observation period with adequate pain control should be given. The optimal length of time for observation prior to intervention remains uncertain; however, in our practice, an observation period of up to two weeks is employed. The goal of management is to minimize renal injury, which requires balancing the risk of a urologic procedure (ie, urinary drainage or stone removal) versus potential chronic renal injury from continued obstruction.",
"   </p>",
"   <p>",
"    In our practice, we intervene if there are signs of infection, complete obstruction, partial obstruction by a stone in a solitary kidney, renal insufficiency, or if the stone is greater than 5 mm in diameter, as it is unlikely to pass spontaneously.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Struvite calculi &ndash; Urologic removal of struvite calculi is generally required to eradicate the underlying infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/9\">",
"       9",
"      </a>",
"      ]. Persistent infection, which is usually due to a urease-producing bacteria (eg, Proteus or Klebsiella), is a risk factor for recurrent stone formation. In addition, struvite stones are usually too large to pass spontaneously as they tend to branch and enlarge, resulting in a filling of the renal calyces producing a \"staghorn\" appearance. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/60/6090?source=see_link&amp;anchor=H15#H15\">",
"       \"Epidemiology of and risk factors for nephrolithiasis in children\", section on 'Infection'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Symptomatic stones that fail to pass after a trial of conservative therapy &ndash; We offer urologic intervention to children with stones that do not spontaneously pass after two weeks. These stones are often located in the kidney and are generally asymptomatic. However, their removal could prevent a potential acute episode of renal colic due to obstruction of the urinary tract. Alternatively, patients can be treated conservatively with hydration and pain control as needed. In patients with uric acid stones, urine alkalinization increases the solubility of uric acid and may result in a decrease in stone size with subsequent passage. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/62/19432?source=see_link&amp;anchor=H14#H14\">",
"       \"Prevention of recurrent nephrolithiasis in children\", section on 'Hyperuricosuria'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urosepsis &ndash; Although not commonly seen in children, urosepsis is a serious and life-threatening complication of nephrolithiasis. In adult patients, urinary drainage is used to lower the intrarenal pelvic pressure due to stone-induced obstruction, which is thought to improve delivery of antibiotics to the infected kidney [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over the past two decades, the following new urologic procedures for stone removal have been developed and adapted to children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. These procedures have generally replaced open surgical repair and can be used in children of all ages, including small children and infants.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Extracorporeal shock wave lithotripsy (ESWL)",
"     </li>",
"     <li>",
"      Percutaneous nephrostolithotomy (PCNL)",
"     </li>",
"     <li>",
"      Ureteroscopy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Extracorporeal shock wave lithotripsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extracorporeal shock wave lithotripsy (ESWL) employs high energy shock waves produced by an electrical discharge. Historically, the child was placed in a water bath and the shock waves were transmitted through the water and directly focused onto the stone with the aid of biplanar fluoroscopy. Second and third generation lithotriptors do not require the water bath, but utilize a contained fluid interface with the patient to transmit the shockwaves. The change in tissue density between the soft renal tissue and the hard stone causes a release of energy at the stone surface, which fragments the stone.",
"   </p>",
"   <p>",
"    For stones that are less than 2 cm in diameter, the resulting fragments are usually passed without difficulty. Stents can be placed when the stone is greater than 2 cm to reduce the risk of obstruction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/15\">",
"     15",
"    </a>",
"    ]. However, in children, the placement and removal of the stent generally requires conscious sedation or general anesthesia. In one case series of 24 children (age range 2 to 14 years), stones between 2.5 and 3.5 cm (mean 3.1 cm) were treated by ESWL without the use of stents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/16\">",
"     16",
"    </a>",
"    ]. At the end of therapy, the overall stone-free rate was 83 percent, and complications occurred in six patients, including ureter obstruction by stone fragments, also referred to as steinstrasse (n = 4), and renal colic (n = 2). Of the four with steinstrasse, one patient required ureteroscopy to relieve the obstruction, and spontaneous stone passage occurred in the other three patients. However, because of the increased morbidity associated with steinstrasse, we continue not to recommend stentless ESWL for stones greater than 2 cm in diameter.",
"   </p>",
"   <p>",
"    We use general anesthesia for ESWL due to the requirements of a completely stationary patient during the procedure and the minimal skin sensation, which an awake child would perceive at the entrance site of the shock wave.",
"   </p>",
"   <p>",
"    ESWL has been shown to be an effective and safe procedure for removing stones in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/11,17,18\">",
"     11,17,18",
"    </a>",
"    ], including small children and infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/12,19-21\">",
"     12,19-21",
"    </a>",
"    ]. However, modifications to ensure proper positioning of the child and appropriate dose of electrical discharge to the size of the patient are required to reduce the likelihood of complications such as hematomas or lung contusions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a large case series, 344 Turkish children (age range 6 months to 14 years) were treated with ESWL over a 12-year period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/11\">",
"     11",
"    </a>",
"    ]. ESWL was performed as an outpatient procedure with administration of conscious sedation, general anesthesia, and no anesthesia in 40, 38, and 22 percent of children, respectively. The following findings were noted at three month follow-up:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      After ESWL, the overall stone-free rate was 73 percent. Stone-free rates varied depending upon the size of the stones and were 92, 68, and 50 percent for stones with diameters smaller than 1 cm, between 1 and 2 cm, and greater than 2 cm in diameter, respectively.",
"     </li>",
"     <li>",
"      The overall stone-free rate for calyceal stones was 56 percent. A higher rate of 63 percent was associated with small stones less than 1 cm and a lower rate of 40 percent with stones with diameters equal to or greater than 1 cm in diameter. ESWL was more likely to fail when stones were located in the lower versus upper pole calyx.",
"     </li>",
"     <li>",
"      Stone-free rates were greater than 90 percent for ureteral and bladder stones regardless of their size.",
"     </li>",
"     <li>",
"      The average number of ESWL sessions per patient was 1.9.",
"     </li>",
"     <li>",
"      Complications were observed in 10 percent of cases (n = 33). Steinstrasse (obstruction by stone fragments) occurred in 13 of 167 children treated for renal pelvic stones. Of the 13 patients with obstruction, 9 had stones greater than 2 cm, and 4 had stones between 1 and 2 cm in diameter. Other complications included stenting for hydronephrosis and urinary tract infections (UTIs). There were no episodes of perirenal hematoma or dermal ecchymosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In another study, a nomogram was developed to predict stone-free rates after ESWL in 412 children. The results show that the overall stone-free rate was 76.7 percent following the first ESWL. Multivariate analysis showed that a prior history of ipsilateral renal stone treatment or increased stone burden was associated with lower stone-free rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although a stone-free status is the preferred outcome after ESWL, some patients will have residual fragments after the procedure. In some cases, these fragments (usually less than 4 mm in diameter) will pass without symptoms, sometimes taking several months to clear. However, in other cases, residual fragments may grow in size and be associated with an increased risk of recurrent symptomatic episodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/2/30756?source=see_link\">",
"     \"Clinical significance of residual stone fragments following stone removal\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20579026\">",
"    <span class=\"h4\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children, limited data suggest there are few short-term and no long-term adverse effects of ESWL upon renal function as demonstrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective review of 128 children treated with ESWL, 22 patients (18 percent) had complications in the postoperative week including 5 with steinstrasse, 14 with decreased oral intake requiring intravenous hydration, 7 with side",
"      <span class=\"nowrap\">",
"       pain/renal",
"      </span>",
"      colic requiring parenteral analgesics, 12 with gross hematuria, and 3 with fever [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a prospective study of 50 children, renal ultrasonography performed after ESWL in 40 patients demonstrated perirenal hematomas in three patients, intrarenal hematoma in two, and subcapsular hematoma in one patient. All hematomas resolved spontaneously [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/18\">",
"       18",
"      </a>",
"      ]. Glomerular filtration rate measured before and after ESWL by 99mTc-diethylenetriamine pentaacetic acid renal scan (DTPA) remained unchanged.",
"     </li>",
"     <li>",
"      In a retrospective study, 99mTc&ndash;",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/22/8548?source=see_link\">",
"       dimercaptosuccinic acid",
"      </a>",
"      (DMSA) renal scans performed in 94 of 182 children before and six months after ESWL detected no new scar formation on post-DMSA scans [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/25\">",
"       25",
"      </a>",
"      ]. Relative renal function of the treated side remained normal in 66 patients, was reduced pre-ESWL and remained unchanged in 18 patients, showed improvement after ESWL in 7 patients, and deteriorated in 2 patients.",
"     </li>",
"     <li>",
"      In a prospective study of 100 children with a mean age of 8 years (range 3 to 14 years) treated from 2005 to 2008, DMSA renal scans performed before and six months after ESWL detected no new scar formation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/26\">",
"       26",
"      </a>",
"      ]. There was also no decrease in the split kidney function as measured by DTPA scan after ESWL with mean GFR values of 113",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      both before and after the last ESWL session. The average number of ESWL sessions was 1.53 and the overall stone-free rate was 88 percent. There were complications in 11 patients due to stone passage including renal colic (n = 8), and lower tract obstruction requiring ureteroscopy for stone removal (n = 3).",
"     </li>",
"     <li>",
"      In a retrospective review of 341 renal units, steinstrasse (ureteral obstruction by stone fragments) occurred in 26 renal units (8 percent). Logistic regression analysis showed that the initial stone burden was associated with steinstrasse. Successful interventions included repeat ESWL in 17 renal units, ureteroscopy after failure of ESWL in four renal units and without ESWL in 1 renal unit, and conservative management in the remaining four units.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20579033\">",
"    <span class=\"h4\">",
"     Renal growth",
"    </span>",
"    &nbsp;&mdash;&nbsp;Follow-up studies have shown no adverse effect on subsequent renal growth.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In 74 children treated at a mean age of nine years (range 9 months to 14 years) with ESWL at a tertiary center in the United States, evaluation of renal growth was performed by measuring renal length by ultrasonography at the time of diagnosis and follow-up [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/27\">",
"       27",
"      </a>",
"      ]. There was no difference in the rate of renal growth between the treated and untreated kidneys at a mean follow-up of 6.2 years (range 1.3 to 13.1 years).",
"     </li>",
"     <li>",
"      In a prospective Egyptian study of 150 children who underwent ESWL between 2005 and 2010, there was no difference in renal growth based on renal ultrasound assessments between patients 12 months after ESWL and controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Percutaneous nephrostolithotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although percutaneous techniques for stone removal were initially introduced in the late 1970s, it was not until the 1990s that instrumentation was adapted to pediatric patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/29\">",
"     29",
"    </a>",
"    ]. Percutaneous nephrostolithotomy (PCNL) entails obtaining percutaneous access to the collecting system, dilating the tract with a balloon dilator, and extracting the stone with grasping forceps or fragmenting the stone with a LASER, ultrasonic, pneumatic, hydraulic, or combined lithotripsy probe. PCNL can be performed in conjunction with ESWL.",
"   </p>",
"   <p>",
"    Stone-free rates of 70 to 90 percent have been reported. Rates vary depending upon the experience of the clinician, the complexity of the stones, and the presence of an underlying structural abnormality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/13,30,31\">",
"     13,30,31",
"    </a>",
"    ]. In one retrospective Egyptian study of children with renal stones between 1 and 2 cm in diameter, the stone-free rates between a single PCNL and one ESWL session were comparable (87 versus 85 percent, respectively) at a mean follow-up of 31 months (range 6 to 84 months) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In children, data on complication rates are limited. Serious adverse events appear to be similar to those reported in adults (who have a complication rate of 4 to 5 percent) and include urosepsis, bleeding (sometimes requiring red blood cell transfusions), renal pelvic perforation, and injury to adjacent organs (eg, hydrothorax and colon perforation) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/13,15,30\">",
"     13,15,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Follow-up data regarding renal function are also lacking. One study using 9mTc-",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/22/8548?source=see_link\">",
"     dimercaptosuccinic acid",
"    </a>",
"    (DMSA) and DTPA renal scans reported no evidence of postoperative scarring after PCNL or impairment of glomerular filtration rate when evaluated six months after the procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Ureteroscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ureteroscopic instrumentation has been adapted for use in pediatric patients as first line therapy and is useful for the management of children with calculi who have failed ESWL, especially those with ureteral stones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/15\">",
"     15",
"    </a>",
"    ]. Once the stone is visualized, it is extracted with grasping forceps or basket, or fragmented with LASER, ultrasonic, or electrohydraulic lithotripsy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/62/30695?source=see_link&amp;anchor=H6#H6\">",
"     \"Options in the management of renal and ureteral stones in adults\", section on 'Ureteroscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although data are limited regarding stone-free rates in children, case series have reported stone-free rates around 90 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/14,32,33\">",
"     14,32,33",
"    </a>",
"    ]. In the largest reported series from a single tertiary center, 115 procedures were performed in 100 patients (mean age 13.2 years) with a stone-free rate of 91 percent at a mean follow-up time of 10.1 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/32\">",
"     32",
"    </a>",
"    ]. Two-thirds of the stones were located in the ureter (17, 11, and 37 percent in the proximal, mid, and distal ureter, respectively). The mean stone size was 8.3 mm and there was a mean of 1.5 stones per patient. Stenting was required in the majority of patients, five of which were required because of ureteral perforation or fluid extravasation.",
"   </p>",
"   <p>",
"    In another case series from a single center that included only prepubertal patients, a stone-free rate of 88 percent was reported in 29 children (mean age 94 months, range 5 to 144 months) after ureteroscopic laser lithotripsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/14\">",
"     14",
"    </a>",
"    ]. Almost all of the stones were within one of the ureters, primarily located in the distal ureter. There was only one reported complication of fluid extravasation at the ureterovesical junction, which was managed by stent placement.",
"   </p>",
"   <p>",
"    In patients with upper tract stones (either renal pelvic or polar stones), successful ureteroscopic removal of stones can be achieved including those located in the lower pool of the kidney [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/34,35\">",
"     34,35",
"    </a>",
"    ], although multiple sessions",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ureteral stenting may be needed.",
"   </p>",
"   <p>",
"    Ureteroscopy is not as successful in the removal of staghorn calculi. This was illustrated in a case series of 19 children with 23 renal calculi that demonstrated clearance of renal pelvic stones in six of eight children (mean number of sessions 1.5), successful clearance of stones in all four children with polar stones after multiple sessions, and clearance in only one of seven children with staghorn calculi [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/35\">",
"     35",
"    </a>",
"    ]. These results suggest that ureteroscopy does not have a role in treating children with staghorn calculi. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/18/40231?source=see_link\">",
"     \"Management of struvite or staghorn calculi\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Stenting",
"    </span>",
"    &nbsp;&mdash;&nbsp;The need for stenting in children who undergo ESWL or ureteroscopy is controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/15\">",
"     15",
"    </a>",
"    ]. Stents are used to prevent ureteric obstruction either from edema due to ureteral injury or residual fragments in ESWL. Studies in adults have demonstrated that patients with stents versus those without stents were more likely to have lower urinary tract symptoms (dysuria, frequency, or urgency), while there was no difference in stone-free rate, and the rates of UTIs, ureteric structures, and analgesic administration. Similar data in children are lacking. In practice, most pediatric urologists do not place a stent in simple, uncomplicated cases of ureteroscopy or in a patient with a stone less than 1.5 to 2 cm in diameter who is treated with ESWL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, pre-stenting (the practice of placing a stent a week or two prior to the ureteroscopic procedure to facilitate ease of passage of the ureteroscopes) has been employed for passive dilation of the ureter. This does place the child at a higher risk for lower urinary tract symptoms and possible infection, but minimizes the need for ureteral dilation at the time of ureteroscopy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Choice of procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Choice of treatment is dictated by the experience of the clinician and the availability of instrumentation adapted for pediatric cases. In centers where the different procedures are available, treatment choices are based upon the stone size and location, presence of an anatomical abnormality, and, if known, stone composition as follows [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/13,15\">",
"     13,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Size &ndash; ESWL is the preferred procedure when stones are radiopaque and small (less than 1 cm in diameter) in the renal pelvis, but not distal ureteral stones in girls because of the position of the ovaries. It is the least invasive procedure with fewer serious complications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients with stones greater than 2 cm in diameter in the kidney, PCNL is the preferred modality for successful stone removal because of the low stone-free rates and difficulty of high stone burden passage produced by ESWL.",
"     </li>",
"     <li>",
"      In patients with stones between 1 and 2 cm in diameter, it is uncertain which is the best modality. As discussed previously, a retrospective study reported comparable stone-free rates for ESWL and PCNL in children with stones between 1 and 2 cm in diameter [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/13\">",
"       13",
"      </a>",
"      ]. If clearance with ESWL is impaired, such as in a child with calyceal diverticulum, PCNL may be preferred. Otherwise, ESWL as an initial therapy is suggested because it is less invasive and has a lower rate of significant complications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Location &ndash; Poorer clearance of renal stone fragments from the lower pole compared with other locations has been reported in adults after ESWL. Similar results have been noted in several case series in children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/11,36\">",
"       11,36",
"      </a>",
"      ]. In contrast, a single report of 126 children from a tertiary center in Egypt demonstrated similar clearance rates regardless of the stone location within the kidney [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Structural abnormality &ndash; Children with underlying structural abnormalities, such as ureteropelvic (UPJ) obstruction and calyceal diverticulum, are at increased risk for developing renal stones. In addition, the underlying anatomical defect prevents effective passage of stone fragments with ESWL. In most centers, PCNL is the preferred procedure for patients with calyceal diverticulum, and in children with UPJ obstruction, either PCNL or ureteroscopy is used for stone removal. Additionally, calyceal diverticular stones may be accessed from a laparoscopic approach with an incision being made over the dilated stone-laden calyx and directly extracting the stones.",
"     </li>",
"     <li>",
"      Composition of stone &ndash; Stones of harder composition, such as cystine and calcium oxalate monohydrate stones, are less amenable to fractionating with ESWL. As an example, in patients with cystine stones, the stone-free success rate is only 50 percent with ESWL, even after four sessions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/38\">",
"       38",
"      </a>",
"      ]. As a result, PCNL or ureteroscopy and LASER lithotripsy are the preferred procedure in these patients. In contrast, struvite, calcium oxalate dihydrate, and uric acid stones break more readily with ESWL and have a high stone-free success rate with ESWL [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38552/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Open surgical repair is rarely, if ever, performed today and is reserved for children who have failed other urologic procedures or those with complex renal or ureteral anatomic abnormalities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Recommended approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;In institutions where different treatment options are available, therapy can be individualized based upon the factors discussed in the previous section as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with stones up to 2 cm in diameter, ESWL or ureteroscopy with lithotripsy are both reasonable options for stone removal.",
"     </li>",
"     <li>",
"      In patients with stones greater than 2 cm in diameter, we suggest ureteroscopy with lithotripsy, or PCNL. If the stone is in the lower pole calyces, these interventions have a greater success rate than ESWL.",
"     </li>",
"     <li>",
"      In patients with an underlying structural abnormality, the choice of therapy is individualized based upon the anatomy, and the size and location of the stone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?26/38/27234?source=see_link\">",
"       \"Patient information: Kidney stones in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/26/15779?source=see_link\">",
"       \"Patient information: Kidney stones in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The acute management of nephrolithiasis in children is directed towards pain control and facilitating passage or removal of the stone(s). Therapeutic choices are dependent upon the severity of pain, the presence of obstruction or infection, and the size and location of the stone.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Indications for hospitalization include urinary obstruction, infection, solitary kidney, the need for parenteral analgesia because of severe pain, or inability to take oral analgesics (eg, vomiting). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      One of the main goals of medical management is to provide adequate pain control. The choice of analgesic agent is dependent upon the severity of pain and the ability of the child to take oral medications. Both nonsteroidal antiinflammatory drugs (NSAIDs) and opioids are used in controlling pain in children with nephrolithiasis. In our practice, we generally use NSAIDs in patients who are managed as an outpatient. In hospitalized patients, toradol and opioid therapy are used for pain management. NSAIDs should be stopped three days before anticipated urologic intervention to minimize the risk of bleeding. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pain control'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20266?source=see_link&amp;anchor=H19#H19\">",
"       \"Diagnosis and acute management of suspected nephrolithiasis in adults\", section on 'Pain control'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest observation with pain control in patients with stones less than 5 mm in diameter versus urologic intervention (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Renal ultrasonography is used to monitor stone movement and passage. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Stone passage'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      During this period of observation, the patient is instructed to strain",
"      <span class=\"nowrap\">",
"       his/her",
"      </span>",
"      urine for stone retrieval. If the stone is retrieved, stone composition is determined by laboratory analysis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Stone retrieval'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with severe debilitating pain refractory to parenteral analgesic therapy require urologic stone removal for pain relief. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other indications for urologic intervention versus observation with medical management for pediatric nephrolithiasis include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In children with significant urinary obstruction, we suggest immediate urologic stone removal (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In children with struvite stones, we recommend urologic stone removal (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/18/40231?source=see_link&amp;anchor=H3#H3\">",
"       \"Management of struvite or staghorn calculi\", section on 'Treatment options'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In symptomatic children who fail to pass a stone after two weeks, we suggest stone removal (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Partially or totally obstructing calculi in children with a solitary kidney.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The choice of urologic procedure is determined by the experience of the clinician and the availability of instrumentation adapted for pediatric cases. Surgical options include extracorporeal shock wave lithotripsy (ESWL), percutaneous nephrostolithotomy (PCNL), and ureteroscopy. These procedures have generally replaced open surgical repair and can be used in children of all ages, including small children and infants. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Procedures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In centers that have different urologic procedures available for stone removal in children, the choice of the procedure is generally based on the size, location, presence of an anatomical abnormality, and, if known, stone composition. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Choice of procedure'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/1\">",
"      Pietrow PK, Pope JC 4th, Adams MC, et al. Clinical outcome of pediatric stone disease. J Urol 2002; 167:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/2\">",
"      Kalorin CM, Zabinski A, Okpareke I, et al. Pediatric urinary stone disease--does age matter? J Urol 2009; 181:2267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/3\">",
"      Aydogdu O, Burgu B, Gucuk A, et al. Effectiveness of doxazosin in treatment of distal ureteral stones in children. J Urol 2009; 182:2880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/4\">",
"      Erturhan S, Bayrak O, Sarica K, et al. Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology 2013; 81:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/5\">",
"      Mokhless I, Zahran AR, Youssif M, Fahmy A. Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study. J Pediatr Urol 2012; 8:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/6\">",
"      Parvex P, Pippi-Salle JL, Goodyer PR. Rapid loss of renal parenchyma after acute obstruction. Pediatr Nephrol 2001; 16:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/7\">",
"      Paryani JP, Ather MH. Improvement in serum creatinine following definite treatment of urolithiasis in patients with concurrent renal insufficiency. Scand J Urol Nephrol 2002; 36:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/8\">",
"      Gupta M, Bolton DM, Gupta PN, Stoller ML. Improved renal function following aggressive treatment of urolithiasis and concurrent mild to moderate renal insufficiency. J Urol 1994; 152:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/9\">",
"      Silverman DE, Stamey TA. Management of infection stones: the Stanford experience. Medicine (Baltimore) 1983; 62:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/10\">",
"      Yoshimura K, Utsunomiya N, Ichioka K, et al. Emergency drainage for urosepsis associated with upper urinary tract calculi. J Urol 2005; 173:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/11\">",
"      Muslumanoglu AY, Tefekli A, Sarilar O, et al. Extracorporeal shock wave lithotripsy as first line treatment alternative for urinary tract stones in children: a large scale retrospective analysis. J Urol 2003; 170:2405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/12\">",
"      Shukla AR, Hoover DL, Homsy YL, et al. Urolithiasis in the low birth weight infant: the role and efficacy of extracorporeal shock wave lithotripsy. J Urol 2001; 165:2320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/13\">",
"      Shokeir AA, Sheir KZ, El-Nahas AR, et al. Treatment of renal stones in children: a comparison between percutaneous nephrolithotomy and shock wave lithotripsy. J Urol 2006; 176:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/14\">",
"      Thomas JC, DeMarco RT, Donohoe JM, et al. Pediatric ureteroscopic stone management. J Urol 2005; 174:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/15\">",
"      Durkee CT, Balcom A. Surgical management of urolithiasis. Pediatr Clin North Am 2006; 53:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/16\">",
"      Shouman AM, Ziada AM, Ghoneim IA, Morsi HA. Extracorporeal shock wave lithotripsy monotherapy for renal stones &gt;25 mm in children. Urology 2009; 74:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/17\">",
"      Rodrigues Netto N Jr, Longo JA, Ikonomidis JA, Rodrigues Netto M. Extracorporeal shock wave lithotripsy in children. J Urol 2002; 167:2164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/18\">",
"      Goel MC, Baserge NS, Babu RV, et al. Pediatric kidney: functional outcome after extracorporeal shock wave lithotripsy. J Urol 1996; 155:2044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/19\">",
"      McLorie GA, Pugach J, Pode D, et al. Safety and efficacy of extracorporeal shock wave lithotripsy in infants. Can J Urol 2003; 10:2051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/20\">",
"      Gofrit ON, Pode D, Meretyk S, et al. Is the pediatric ureter as efficient as the adult ureter in transporting fragments following extracorporeal shock wave lithotripsy for renal calculi larger than 10 mm.? J Urol 2001; 166:1862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/21\">",
"      Landau EH, Shenfeld OZ, Pode D, et al. Extracorporeal shock wave lithotripsy in prepubertal children: 22-year experience at a single institution with a single lithotriptor. J Urol 2009; 182:1835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/22\">",
"      Onal B, Tansu N, Demirkesen O, et al. Nomogram and scoring system for predicting stone-free status after extracorporeal shock wave lithotripsy in children with urolithiasis. BJU Int 2013; 111:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/23\">",
"      Afshar K, McLorie G, Papanikolaou F, et al. Outcome of small residual stone fragments following shock wave lithotripsy in children. J Urol 2004; 172:1600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/24\">",
"      Yucel S, Akin Y, Danisman A, Guntekin E. Complications and associated factors of pediatric extracorporeal shock wave lithotripsy. J Urol 2012; 187:1812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/25\">",
"      Griffin SJ, Margaryan M, Archambaud F, et al. Safety of shock wave lithotripsy for treatment of pediatric urolithiasis: 20-year experience. J Urol 2010; 183:2332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/26\">",
"      Fayad A, El-Sheikh MG, Abdelmohsen M, Abdelraouf H. Evaluation of renal function in children undergoing extracorporeal shock wave lithotripsy. J Urol 2010; 184:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/27\">",
"      Reisiger K, Vardi I, Yan Y, et al. Pediatric nephrolithiasis: does treatment affect renal growth? Urology 2007; 69:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/28\">",
"      Fayad A, El-Sheikh MG, El-Fayoumy H, et al. Effect of extracorporeal shock wave lithotripsy on kidney growth in children. J Urol 2012; 188:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/29\">",
"      Jackman SV, Hedican SP, Peters CA, Docimo SG. Percutaneous nephrolithotomy in infants and preschool age children: experience with a new technique. Urology 1998; 52:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/30\">",
"      Bilen CY, Ko&ccedil;ak B, Kitirci G, et al. Percutaneous nephrolithotomy in children: lessons learned in 5 years at a single institution. J Urol 2007; 177:1867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/31\">",
"      Dawaba MS, Shokeir AA, Hafez A, et al. Percutaneous nephrolithotomy in children: early and late anatomical and functional results. J Urol 2004; 172:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/32\">",
"      Smaldone MC, Cannon GM Jr, Wu HY, et al. Is ureteroscopy first line treatment for pediatric stone disease? J Urol 2007; 178:2128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/33\">",
"      Dogan HS, Onal B, Satar N, et al. Factors affecting complication rates of ureteroscopic lithotripsy in children: results of multi-institutional retrospective analysis by Pediatric Stone Disease Study Group of Turkish Pediatric Urology Society. J Urol 2011; 186:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/34\">",
"      Kim SS, Kolon TF, Canter D, et al. Pediatric flexible ureteroscopic lithotripsy: the children's hospital of Philadelphia experience. J Urol 2008; 180:2616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/35\">",
"      Dave S, Khoury AE, Braga L, Farhat WA. Single-institutional study on role of ureteroscopy and retrograde intrarenal surgery in treatment of pediatric renal calculi. Urology 2008; 72:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/36\">",
"      Tan MO, Kirac M, Onaran M, et al. Factors affecting the success rate of extracorporeal shock wave lithotripsy for renal calculi in children. Urol Res 2006; 34:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/37\">",
"      Demirkesen O, Onal B, Tansu N, et al. Efficacy of extracorporeal shock wave lithotripsy for isolated lower caliceal stones in children compared with stones in other renal locations. Urology 2006; 67:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/38\">",
"      Slavkovi A, Radovanovi M, Siri Z, et al. Extracorporeal shock wave lithotripsy for cystine urolithiasis in children: outcome and complications. Int Urol Nephrol 2002; 34:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38552/abstract/39\">",
"      Al-Busaidy SS, Prem AR, Medhat M. Pediatric staghorn calculi: the role of extracorporeal shock wave lithotripsy monotherapy with special reference to ureteral stenting. J Urol 2003; 169:629.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6114 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-427C511A25-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38552=[""].join("\n");
var outline_f37_41_38552=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MEDICAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pain control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Urine culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Stone passage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Stone retrieval",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      UROLOGIC INTERVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Procedures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Extracorporeal shock wave lithotripsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H20579026\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H20579033\">",
"      Renal growth",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Percutaneous nephrostolithotomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Ureteroscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Stenting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Choice of procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Recommended approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=related_link\">",
"      Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/19/13623?source=related_link\">",
"      Clinical features and diagnosis of nephrolithiasis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/2/30756?source=related_link\">",
"      Clinical significance of residual stone fragments following stone removal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20266?source=related_link\">",
"      Diagnosis and acute management of suspected nephrolithiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/60/6090?source=related_link\">",
"      Epidemiology of and risk factors for nephrolithiasis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/18/40231?source=related_link\">",
"      Management of struvite or staghorn calculi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/62/30695?source=related_link\">",
"      Options in the management of renal and ureteral stones in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/26/15779?source=related_link\">",
"      Patient information: Kidney stones in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?26/38/27234?source=related_link\">",
"      Patient information: Kidney stones in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/29/31194?source=related_link\">",
"      Pharmacologic agents for pediatric procedural sedation outside of the operating room",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/62/19432?source=related_link\">",
"      Prevention of recurrent nephrolithiasis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/3/25658?source=related_link\">",
"      Selection of medications for pediatric procedural sedation outside of the operating room",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_41_38553="Comorbid anxiety and depression: Epidemiology, clinical manifestations, and diagnosis";
var content_f37_41_38553=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Comorbid anxiety and depression: Epidemiology, clinical manifestations, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38553/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38553/contributors\">",
"     Michael Van Ameringen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38553/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38553/contributors\">",
"     Murray B Stein, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/41/38553/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/41/38553/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/41/38553/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 28, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H32457350\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anxiety disorders and depressive disorders are highly prevalent conditions that frequently co-occur. Individuals affected by both anxiety and depressive disorders concurrently have generally shown greater levels of functional impairment, reduced quality of life, and poorer treatment outcomes compared with individuals with only one disorder.",
"   </p>",
"   <p>",
"    Study of the clinical presentation, course, assessment, and diagnosis of these conditions have largely focused on the co-occurrence of depression and generalized anxiety disorder. The diagnosis of these conditions is complicated by the presence of mixed anxiety and mood states as well as substantial overlap in physical and emotional symptoms of the disorders.",
"   </p>",
"   <p>",
"    This topic describes the epidemiology, pathogenesis, clinical manifestations, course, and diagnosis of comorbid anxiety and depression. The treatment of comorbid anxiety and depression is discussed elsewhere. The epidemiology, pathogenesis, clinical manifestations, course, diagnosis, and treatment of individual depressive and anxiety disorders are also described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37481?source=see_link\">",
"     \"Unipolar depression in adults: Epidemiology, pathogenesis, and neurobiology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/13/11481?source=see_link\">",
"     \"Clinical manifestations and diagnosis of depression\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/19/38201?source=see_link\">",
"     \"Unipolar depression in adults: Prognosis and course of illness\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/0/32776?source=see_link\">",
"     \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/44/44744?source=see_link\">",
"     \"Social anxiety disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36564?source=see_link\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44713?source=see_link\">",
"     \"Panic disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/15/10488?source=see_link\">",
"     \"Agoraphobia in adults: Epidemiology, clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457357\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457364\">",
"    <span class=\"h2\">",
"     Population-based samples",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a high rate of comorbid anxiety and depressive disorders in population-based samples. The lifetime prevalence of anxiety disorders and major depression among adults in the United States (US) has been reported to be 28.8 percent and 16.6 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Three international studies found that depression is significantly associated with every anxiety disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/1-3\">",
"     1-3",
"    </a>",
"    ], with the highest associations in patients with generalized anxiety disorder (GAD) and the lowest in those with agoraphobia and specific phobias.",
"   </p>",
"   <p>",
"    Lifetime prevalence of comorbid anxiety and depression in the general population is very high. In a recent study of 1783 individuals, 75 percent of those with depression met criteria for an anxiety disorder in their lifetime; 79 percent of those with an anxiety disorder met criteria for lifetime major depression (",
"    <a class=\"graphic graphic_table graphicRef86955 \" href=\"mobipreview.htm?10/29/10718\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study found that the 12-month prevalence of comorbid mood and anxiety disorders (3.5 percent) in the Netherlands was higher than the prevalence of a pure mood disorder (ie, a mood disorder without a co-occurring anxiety disorder, eating disorder, or schizophrenia; 3.1 percent) but lower than pure anxiety disorder (7.7 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/5\">",
"     5",
"    </a>",
"    ]. Of patients with mood disorders, 60.5 percent were diagnosed as having another mental disorder. Anxiety disorders were the most common category of disorders, with a prevalence of 53.4 percent among patients with a co-occurring disorder.",
"   </p>",
"   <p>",
"    In a community sample of 915 women age 42 to 52 years, 10.7 percent reported lifetime history of an anxiety disorder and major depression concurrently, 53 percent reported no lifetime history of either disorder, 13.8 percent reported a history of an anxiety disorder alone, and 22.1 percent had a history of depression alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457371\">",
"    <span class=\"h2\">",
"     Clinical samples",
"    </span>",
"    &nbsp;&mdash;&nbsp;High rates of comorbidity between anxiety disorders and depression have been observed in samples of patients receiving mental health care.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Studies of patients with anxiety disorders have yielded a point prevalence of comorbid depression ranging from 2 to 69 percent, with lifetime rates as high as 81 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/7-10\">",
"       7-10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a sample of 1127 outpatients with anxiety disorders, current and lifetime prevalence rates of mood disorders were 57 and 81 percent, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/10\">",
"       10",
"      </a>",
"      ]. In those with a primary anxiety disorder, 30 percent met criteria for a comorbid mood disorder (major depression",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      dysthymia). The prevalence of comorbid major depression ranged from 3 percent in specific phobia to 69 percent in posttraumatic stress disorder.",
"     </li>",
"     <li>",
"      In a sample of 468 patients with DSM-III-R anxiety disorders, 11 percent suffered from comorbid depression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/9\">",
"       9",
"      </a>",
"      ]. Prevalence ranged from 4 percent for specific phobias to 36 percent for severe panic disorder with agoraphobia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Small studies of samples of patients with depressive disorders have yielded variations in the point prevalence of comorbid anxiety of 44.7 to 92.1 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/11-13\">",
"     11-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an analysis of 255 depressed outpatients, 44.7 percent met diagnostic criteria for an anxiety disorder [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a sample of 72 inpatients with major depression, 54.1 percent met diagnostic criteria for at least one anxiety disorder [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a sample of 120 depressed patients who were participating in a genetics study, the odds of having a comorbid anxiety disorder with &ldquo;familial&rdquo; MDD were 6.6 (95% CI, 3.8&ndash;11.4, p&lt;0.001) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457378\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Analyses of data of 3021 individuals from the Early Developmental Stages of Psychopathology (EDSP) study have been used to assess risk factors, temporal patterns, and longitudinal outcomes of anxiety, depression, and co-occurring anxiety and depressive disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study examined the relationship between risk factors for anxiety disorders compared to depressive disorders and to co-occurring anxiety and depressive disorders [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/15\">",
"       15",
"      </a>",
"      ]. Factors common to both disorder classes were: female gender, perinatal factors, and parental psychiatric history. Risk factors for the co-occurrence were a direct combination of the risk factors for either disorder alone. There were no risk factors detected specific to comorbid anxiety and depression that were not risk factors for the individual disorders as well.",
"     </li>",
"     <li>",
"      The risk of depression in individuals with anxiety disorders was significantly associated with female gender, number of anxiety disorder diagnoses, severity of anxiety disorder at baseline, and the presence of panic attacks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study found that individuals with social phobia were significantly more likely to develop depression compared to those without the disorder. This effect was greatest for individuals who developed social phobia before the age of 16 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An epidemiological study of a nationally representative sample of 7076 adults in the Netherlands found the following factors to be associated with co-occurring anxiety and mood disorders compared to either disorder in its pure form [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Female gender",
"     </li>",
"     <li>",
"      Younger age (25 to 34 years)",
"     </li>",
"     <li>",
"      Lower education level",
"     </li>",
"     <li>",
"      Living alone",
"     </li>",
"     <li>",
"      Unemployment",
"     </li>",
"     <li>",
"      Parental psychiatric history",
"     </li>",
"     <li>",
"      Childhood trauma",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457385\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;While our understanding of the etiology of co-occurring anxiety and depression is limited, research has identified similarities between the two disorders in their neurobiology, genetic structure, and presence of neuroticism and harm avoidance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457393\">",
"    <span class=\"h2\">",
"     Neurobiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Research findings suggest that mood and anxiety symptoms result from a disruption in the balance of impulses from the brain&rsquo;s limbic system.",
"   </p>",
"   <p>",
"    Brain imaging studies have most consistently implicated the amygdala, anterior cingulate cortex, and insula in the pathophysiology of anxiety [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/18\">",
"     18",
"    </a>",
"    ]. As examples, neuroimaging studies in PTSD, social phobia, and specific phobia found significant hyperactivity in the amygdala and insula across all three disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/19\">",
"     19",
"    </a>",
"    ]. Neuroimaging studies in depression have not been as consistent. Evidence suggests abnormal activity levels in the anterior cingulate, dorsolateral, medial and inferior prefrontal cortex, insula, superior temporal gyrus, basal ganglia and cerebellum.",
"   </p>",
"   <p>",
"    The most consistent abnormality across both disorder classes has been found to be hyperactivity within the amygdala. This hyperactivity appears to manifest differently in anxiety and depression. In depressed patients, baseline amygdalar activity is higher than healthy controls; however, in patients with anxiety disorders, amygdalar activation is higher only during provocation tasks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457400\">",
"    <span class=\"h2\">",
"     Neuropsychological factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Personality traits and neuropsychological factors may play a role in the risk for co-occurring depression and anxiety disorders. In two, large-scale studies, neuroticism was found to be the strongest and most significant predictor of comorbidity between different disorders, particularly anxiety and depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. One of the studies examined whether comorbid anxiety and depression differed from either disorder cluster alone on neuropsychological and genetic dimensions, finding that those with the co-occurring disorders had:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Greater impairments in working memory and attention compared with those with an anxiety disorder alone.",
"     </li>",
"     <li>",
"      Higher levels of harm avoidance and neuroticism compared with patients with depression alone, anxiety alone, or substance and alcohol disorders alone.",
"     </li>",
"     <li>",
"      A greater likelihood of having two distinct genetic markers for harm avoidance (catechol-O-methyltransferase [COMT] Met158 and brain derived neurotrophic factor [BDNF] Met66) compared with either disorder alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457407\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two studies suggest that the comorbidity between anxiety (generalized anxiety disorder [GAD] in particular) and depressive disorder could be explained in part by similarities in genetic structure.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study of more than 5600 same-sex twin pairs attempted to decipher the heritability of common psychiatric disorders [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/24\">",
"       24",
"      </a>",
"      ]. Multivariate twin modeling analysis was used to examine clustering of DSM-III-R symptoms. Vulnerability to these phenotypes could be grouped into two clusters for anxiety and depression. The first cluster described risk for depression and generalized anxiety disorder while the second cluster described a broad risk for phobic disorders. Risk for panic disorder was shared by both clusters.",
"     </li>",
"     <li>",
"      Another analysis of same-sex twin pairs from the Virginia Twin Study showed a similar two factor structure, with GAD, panic, agoraphobia and, to some extent, social anxiety disorder in one cluster and specific phobias in another [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Twin studies have suggested that the anxiety disorders and major depression were distinct entities and not simply phases of the same disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/26\">",
"     26",
"    </a>",
"    ]. A possible explanation for the comorbidity between anxiety and depression is a common genetic etiology and the presence of neuroticism with environmental factors playing a small role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1127765512\">",
"    <span class=\"h2\">",
"     Conceptual issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anxiety and depression overlap in some cognitive components and clinical symptoms (",
"    <a class=\"graphic graphic_table graphicRef87209 \" href=\"mobipreview.htm?35/34/36395\">",
"     table 2",
"    </a>",
"    ). In the tripartite model of emotion, a prevailing conceptual theory for emotional disorders, anxiety, and depression can be deconstructed into three principal components: negative affect, physiologic hyperarousal, and low positive affect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Negative affect encompasses a wide range of negative emotional responses from fear and distress to disgust and anger. Negative affect is seen in both anxiety and depression.",
"     </li>",
"     <li>",
"      Low positive affect describes a state lacking positive emotional responses, such as happiness or pleasure. Positive emotional responses are absent in depression, but not in anxiety disorders.",
"     </li>",
"     <li>",
"      Physiologic hyperarousal is characteristic of anxiety disorders but not depression. Signs and symptoms include excessive agitation, edginess, and feeling &ldquo;keyed up&rdquo; or tense.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Overlap between anxiety and depression can be partially explained by the shared concept of negative affect. This conceptualization was supported in a study of outpatients with moderate levels of psychopathology and DSM-III diagnoses of major depression (262 patients), dysthymia (82), panic disorder (156), or generalized anxiety disorder (79) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/28\">",
"     28",
"    </a>",
"    ]. Factor analysis found 12 symptom components.",
"   </p>",
"   <p>",
"    Depression was best explained by the presence of:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Negative self-view",
"     </li>",
"     <li>",
"      Anhedonia",
"     </li>",
"     <li>",
"      Dysphoria",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Anxiety was best explained by the presence of:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Panic attacks",
"     </li>",
"     <li>",
"      Threatening thoughts",
"     </li>",
"     <li>",
"      Subjective worry and tension",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Negative affect (eg, anhedonia, worry, and tension) was shared by both depression and anxiety. Physiologic hyperarousal (panic attacks) was unique to anxiety. Low positive affect (dysphoria) was unique to depression. Among all the factors, negative self-view had the largest influence, accounting for 17.1 percent of the variance seen in anxiety and depression.",
"   </p>",
"   <p>",
"    The study showed areas of symptom overlap between anxiety and depression. Using the factor structure to predict each diagnosis, strong reliability was found for major depression and panic disorder. However, two-thirds of those diagnosed with GAD were misclassified as having panic disorder or major depression, indicating substantial overlap in symptoms.",
"   </p>",
"   <p>",
"    A similar pattern of symptom overlap in major depression and anxiety disorders has been seen in other outpatient samples. An analysis of mean scores on anxiety and depression rating scales in 126 outpatients referred to an anxiety specialty clinic found substantial overlap between the two disorder classes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/29\">",
"     29",
"    </a>",
"    ]. Patients with major depression scored significantly higher on the anxiety scale than those with social phobia. Patients with major depression and patients with OCD had the highest scores on the depression rating scale, with no differences observed among patients with one of the other anxiety disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H428203\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Study of the clinical presentation of anxiety co-occurring with depression has largely focused on symptoms of generalized anxiety disorder (",
"    <a class=\"graphic graphic_table graphicRef55612 \" href=\"mobipreview.htm?28/54/29547\">",
"     table 3",
"    </a>",
"    ). Co-occurring generalized anxiety disorder (GAD) and depression can present on a continuum, from principally anxiety symptoms to mixed anxiety and depression, to principally depressive symptoms.",
"   </p>",
"   <p>",
"    Some of the symptoms of GAD and depression are characteristic of both disorders, while others are specific to GAD or depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/30\">",
"     30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptoms specific to depression:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Loss of interest",
"     </li>",
"     <li>",
"      Weight change",
"     </li>",
"     <li>",
"      Poor appetite",
"     </li>",
"     <li>",
"      Motor retardation",
"     </li>",
"     <li>",
"      Guilt or worthlessness",
"     </li>",
"     <li>",
"      Thoughts of death",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptoms common to GAD and depression:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Dysphoric mood",
"     </li>",
"     <li>",
"      Irritability",
"     </li>",
"     <li>",
"      Agitation or restlessness",
"     </li>",
"     <li>",
"      Concentration difficulties",
"     </li>",
"     <li>",
"      Insomnia",
"     </li>",
"     <li>",
"      Fatigue",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptoms specific to GAD:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Excessive worry",
"     </li>",
"     <li>",
"      Autonomic hyperactivity",
"     </li>",
"     <li>",
"      Exaggerated startle response",
"     </li>",
"     <li>",
"      Muscle tension",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457507\">",
"    <span class=\"h1\">",
"     COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comorbid anxiety (symptoms of generalized anxiety disorders or GAD) and depressive disorders have been found to differ from the individual disorder categories in age of onset [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/1,13,31\">",
"     1,13,31",
"    </a>",
"    ], life course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/32\">",
"     32",
"    </a>",
"    ], and treatment outcome. Presence of both disorders together significantly decreases the odds of recovery, increases the time to therapeutic onset for pharmacotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/1,15\">",
"     1,15",
"    </a>",
"    ], and is associated with a more chronic course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/33\">",
"     33",
"    </a>",
"    ]. However, the course of the co-occurring conditions can be complex.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457414\">",
"    <span class=\"h2\">",
"     Onset and life course",
"    </span>",
"    &nbsp;&mdash;&nbsp;Age of onset patterns for anxiety and mood disorders appear distinct. In a 2005 nationally representative epidemiological study in the US, the median age of onset was 11 years for anxiety disorders and 30 years for mood disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data from the Early Developmental Stages of Psychopathology (EDSP) study found that [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/15\">",
"     15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Onset of anxiety was most likely to occur early in life, with few new cases after age 20",
"     </li>",
"     <li>",
"      Prevalence of major depression increased significantly after age 20",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Age of onset for comorbid anxiety and depressive disorders varied depending on which disorder class was used as the indexing disorder. For an anxiety disorder with comorbid depression, age of onset for the comorbid conditions closely followed that of an anxiety disorder alone. The age of onset for a depressive disorder and comorbid anxiety disorder closely followed that of a depressive disorder alone.",
"   </p>",
"   <p>",
"    Age of onset appears to vary by anxiety disorder. Subsequent EDSP analysis with additional follow-up data found that age of onset for GAD, panic disorder, and agoraphobia was generally in adolescence and early adulthood (similar to depression), while social anxiety disorder and specific phobias began in early childhood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/31\">",
"     31",
"    </a>",
"    ]. In a study of 255 depressed outpatients, 44.7 percent met diagnostic criteria for an anxiety disorder. The onset of both social anxiety disorder and GAD was more likely to precede the development of major depression, with the opposite being true for obsessive-compulsive disorder, panic disorder, agoraphobia, and simple phobias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Co-occurrence of anxiety and depression is associated with a more chronic course compared with either disorder alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/33\">",
"     33",
"    </a>",
"    ]. Analysis of data from a nationally representative epidemiologic study in the US found that, compared with individuals without GAD, patients with a primary lifetime diagnosis of GAD had an increased likelihood of both subsequent onset and persistence of a major depressive episode (MDE). A primary lifetime diagnosis of a MDE predicted the onset but not persistence of GAD. The study found that a temporal association between a MDE and GAD was highest among respondents aged 15 to 24 years. More than one-third of individuals with co-occurring MDE and GAD experienced the onset of both disorders within the same year. Despite the more chronic presentation, few differences in functional impairment have been observed between comorbid anxiety and depression and either disorder alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Depression is generally episodic in nature with modest rates of recovery, but rates of relapse are high. Anxiety disorders conversely tend to be chronic and unremitting, with low levels of recovery and moderate levels of relapse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Co-occurring anxiety disorders and depression may have a worse course than the anxiety disorder alone:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a 12-year prospective study of patients with GAD or panic disorder with or without agoraphobia, those with comorbid major depression were half as likely to recover, compared with either disorder alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Data from the National Epidemiologic Survey of Alcohol and Related Conditions study indicated that those with GAD and major depression were significantly more impaired in perceived mental health quality and social functioning, compared with those with GAD alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A 15-year prospective analysis found that prevalence of anxiety and depression together did not change over the course of the study, while prevalence of anxiety alone and depression alone increased over time [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/35\">",
"       35",
"      </a>",
"      ]. This finding suggests that comorbid anxiety and depression is a more stable condition than either disorder alone. Once comorbidity develops, it is unlikely that an individual will experience a recurrence of either disorder alone, particularly anxiety.",
"     </li>",
"     <li>",
"      In a community sample of 915 women age 42 to 52 years, women with a lifetime history of a co-occurring anxiety disorder and major depression were more likely to report a history that included recurrent major depression, multiple lifetime anxiety disorders, higher rates of treatment-seeking, and current elevations in current anxiety and depressive symptoms, compared with women without a history of a anxiety disorder or major depression occurring concurrently or separately [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457428\">",
"    <span class=\"h2\">",
"     Treatment response",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of both depression and anxiety appears to have a poorer response to treatment than either disorder individually:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Sequenced Treatment Alternative to Relieve Depression (STAR*D) trial, outpatients with anxious depression (ie, a diagnosis of major depression and a",
"      <span class=\"nowrap\">",
"       anxiety/somatization",
"      </span>",
"      subscale score greater than seven on the Hamilton Rating Scale for Depression) had significantly lower response and remission rates, compared with patients with non-anxious depression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/36\">",
"       36",
"      </a>",
"      ]. Depressed patients with anxiety took longer to improve than depressed patients without anxiety [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In multiple clinical trials of patients diagnosed with anxiety disorders (GAD, panic disorder, social anxiety disorder, and OCD), the presence of co-occurring depression has been associated with poorer response of the anxiety disorder to pharmacotherapy and psychotherapy, compared with those with the anxiety disorders alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/38-42\">",
"       38-42",
"      </a>",
"      ]. These trials suffered from several methodologic limitations, including that participants with comorbid depression had more severe symptoms of anxiety at baseline in some of the trials. Findings on functional outcomes and change in depressive symptoms were mixed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457435\">",
"    <span class=\"h1\">",
"     ASSESSMENT AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A diagnostic assessment for potential co-occurring anxiety disorders and depressive disorders should include careful patient history, a complete physical examination, and appropriate laboratory studies. The medical history should address medical illnesses, medication side effects, and substance abuse that can produce anxiety or anxiety-like symptoms (",
"    <a class=\"graphic graphic_table graphicRef58758 \" href=\"mobipreview.htm?10/16/10508\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef54521 \" href=\"mobipreview.htm?1/61/2013\">",
"     table 5",
"    </a>",
"    ) or depressive symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37481?source=see_link&amp;anchor=H13#H13\">",
"     \"Unipolar depression in adults: Epidemiology, pathogenesis, and neurobiology\", section on 'Secondary depression'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The psychosocial history should screen for stressful life events, family psychiatric history, current social history, substance abuse history (including caffeine, nicotine, and alcohol), and past sexual, physical, and emotional abuse, or emotional neglect.",
"   </p>",
"   <p>",
"    Diagnosis of co-occurring depressive and anxiety disorders is based on DSM-IV-TR criteria for the individual disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/43\">",
"     43",
"    </a>",
"    ]. Two syndromes &mdash; mixed anxiety and depression, and anxious depression &mdash; include symptoms of anxiety, depression or both that are beneath the threshold required by DSM-IV-TR criteria for individual anxiety or depressive disorders. These emerging constructs may prove to be clinically useful, but require further research.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1127765585\">",
"    <span class=\"h2\">",
"     Co-occurring depression and anxiety",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Major depressive disorder (MDD) (",
"      <a class=\"graphic graphic_table graphicRef70852 \" href=\"mobipreview.htm?17/21/17756\">",
"       table 6",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Dysthymia (",
"      <a class=\"graphic graphic_table graphicRef82785 \" href=\"mobipreview.htm?26/4/26700\">",
"       table 7",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Generalized anxiety disorder (GAD) (",
"      <a class=\"graphic graphic_table graphicRef55612 \" href=\"mobipreview.htm?28/54/29547\">",
"       table 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Obsessive-compulsive disorder (",
"      <a class=\"graphic graphic_table graphicRef78513 \" href=\"mobipreview.htm?15/1/15387\">",
"       table 8",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Panic disorder (",
"      <a class=\"graphic graphic_table graphicRef73966 \" href=\"mobipreview.htm?37/9/38044\">",
"       table 9",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Social anxiety disorder (",
"      <a class=\"graphic graphic_table graphicRef66613 \" href=\"mobipreview.htm?33/15/34043\">",
"       table 10",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Posttraumatic stress disorder (",
"      <a class=\"graphic graphic_table graphicRef57500 \" href=\"mobipreview.htm?8/55/9085\">",
"       table 11",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Specific phobia (",
"      <a class=\"graphic graphic_table graphicRef81555 \" href=\"mobipreview.htm?38/54/39787\">",
"       table 12",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Agoraphobia (",
"      <a class=\"graphic graphic_table graphicRef60377 \" href=\"mobipreview.htm?21/41/22171\">",
"       table 13",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H538333\">",
"    <span class=\"h2\">",
"     Mixed anxiety and depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mixed anxiety and depression (MAD) has been defined in the International Classification of Diseases, 10",
"    <sup>",
"     th",
"    </sup>",
"    Revision (ICD-10) as a condition where the symptoms of both anxiety and depression are present for at least one month, with neither being clearly predominant nor sufficient to meet diagnostic criteria for either an anxiety or a depressive disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/44\">",
"     44",
"    </a>",
"    ]. ICD-10 does not provide additional criteria for diagnosing the disorder. Mixed anxiety and depression appears in the appendix of DSM-IV-TR as a proposed disorder for further study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/45\">",
"     45",
"    </a>",
"    ], with proposed diagnostic criteria including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A four-week history of dysphoric mood",
"     </li>",
"     <li>",
"      Four of 10 specific symptoms of anxiety or depression",
"     </li>",
"     <li>",
"      Significant impairment",
"     </li>",
"     <li>",
"      The symptoms are not induced by a medical condition, medication or substances",
"     </li>",
"     <li>",
"      Meeting current criteria for another mood or anxiety disorder or meeting past criteria for MDD, GAD or panic disorder would exclude an individual from a diagnosis of MAD",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While not frequently observed in clinical psychiatric settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/46\">",
"     46",
"    </a>",
"    ], data on the prevalence of MAD in primary care settings are mixed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An epidemiologic study in Munich, Germany found a rate of 0.8 percent in the general population for MAD using diagnostic criteria based on ICD-10 principles [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/46\">",
"       46",
"      </a>",
"      ]. The low rate was surprising given that the rates of subthreshold DSM-III anxiety and depression were 21.9 percent and 2.4 percent respectively. Patients with MAD had significantly more psychosocial impairments, remitted less, and showed greater help-seeking behavior compared with those with anxiety or depression alone.",
"     </li>",
"     <li>",
"      In 78 primary care patients without known psychiatric illness, assessment with a structured clinical interview showed that 12.8 percent of the sample met criteria for MAD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/47\">",
"       47",
"      </a>",
"      ]. The functional impairment associated with a diagnosis of MAD was comparable to the impairment experienced by individuals with full-syndromal anxiety or depressive disorders.",
"     </li>",
"     <li>",
"      In a sample of 1634 primary care patients, a structured assessment found that 0.2 percent met the DSM-IV-TR proposed criteria for MAD. The degree of functional impairment did not differ between individuals with MAD and those with an anxiety disorder only. At six and 12-month follow-up assessments of patients diagnosed with MAD, remission rates were 70 and 8 percent, respectively. The study suggests that the diagnosis of DSM-IV MAD may not be stable over time [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study of 65 primary care patients who screened positive for symptoms of anxiety and depression at an office visit identified 37 patients who did not meet criteria for an anxiety or depressive disorder [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/49\">",
"       49",
"      </a>",
"      ]. None of the 37 patients reported, when asked, that the symptoms of depression and anxiety significantly interfered with their functioning. These findings do not support the need for an additional diagnosis of mixed anxiety-depression disorder beyond the mood and anxiety disorders in DSM-IV-TR.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H538340\">",
"    <span class=\"h2\">",
"     Anxious depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;A proposed disorder, anxious depression, combines criteria of a major depressive episode with an",
"    <span class=\"nowrap\">",
"     anxiety/somatization",
"    </span>",
"    subscale score greater than seven on the Hamilton Rating Scale for Depression (HAM-D). Analyses of data from the Sequenced Treatment Alternative to Relieve Depression (STAR*D) clinical effectiveness trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/36,50\">",
"     36,50",
"    </a>",
"    ] support establishing this diagnosis.",
"   </p>",
"   <p>",
"    In an analysis of data on 1450 outpatients meeting DSM-IV-TR criteria for major depression, 46 percent had a HAM-D",
"    <span class=\"nowrap\">",
"     anxiety/somatization",
"    </span>",
"    subscale score &ge;7. Compared with depressed patients without high levels of anxiety, these patients were more likely to be [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/50\">",
"     50",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Older",
"     </li>",
"     <li>",
"      Less educated",
"     </li>",
"     <li>",
"      Severely depressed",
"     </li>",
"     <li>",
"      Suicidal",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Their rates of treatment response and remission were significantly lower, with a greater time to the onset of a clinical response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/37\">",
"     37",
"    </a>",
"    ]. The absence of agreed upon diagnostic criteria for anxious depression has hindered study of this group. Further research is needed to determine whether anxious depression is a clinically relevant subtype of major depression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H538605\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnoses of individual anxiety disorders and depressive disorders are described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37481?source=see_link\">",
"     \"Unipolar depression in adults: Epidemiology, pathogenesis, and neurobiology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/13/11481?source=see_link\">",
"     \"Clinical manifestations and diagnosis of depression\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/19/38201?source=see_link\">",
"     \"Unipolar depression in adults: Prognosis and course of illness\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/0/32776?source=see_link\">",
"     \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/44/44744?source=see_link\">",
"     \"Social anxiety disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36564?source=see_link\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44713?source=see_link\">",
"     \"Panic disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/15/10488?source=see_link\">",
"     \"Agoraphobia in adults: Epidemiology, clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A table distinguishes among symptoms shared by depression and GAD, symptoms specific to depression, and symptoms specific to GAD (",
"    <a class=\"graphic graphic_table graphicRef87209 \" href=\"mobipreview.htm?35/34/36395\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457450\">",
"    <span class=\"h2\">",
"     Diagnostic reliability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the overlap in DSM-IV diagnostic criteria for depression and anxiety disorders, the accuracy of diagnosis of these disorders has been questioned, and study findings have been mixed:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A study of clinical diagnosis in 362 outpatients found good to excellent inter-rater reliability for the disorders [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/51\">",
"       51",
"      </a>",
"      ]. Structured interviews were conducted by clinical psychologists and advanced graduate students.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A cross-sectional study found evidence of poor diagnostic accuracy in clinical samples of 666 patients with &ldquo;pure&rdquo; GAD, 772 &ldquo;pure&rdquo; with a major depressive episode, and 278 with co-occurring GAD and major depression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/52\">",
"       52",
"      </a>",
"      ]. Primary care clinicians made accurate diagnoses in only 34 percent of patients with GAD and 64 percent of patients with a major depressive episode.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32457457\">",
"    <span class=\"h2\">",
"     Rating scales",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scales that have demonstrated good reliability and validity in the assessment of anxiety and depression, either presenting individually or co-occurring, include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Depression and anxiety",
"      </strong>",
"      &mdash; The Depression and Anxiety Stress Scale (DASS) is potentially the most useful instrument for the assessment of patients with co-occurring depression and GAD symptoms, or when discrimination among mixed anxiety and depressive symptoms is unclear [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/53\">",
"       53",
"      </a>",
"      ]. DASS has been shown to be reliable, accurate in its assessment of global anxiety, and able to separate anxiety and depressive symptoms.",
"     </li>",
"     <li>",
"      <strong>",
"       Depression",
"      </strong>",
"      &mdash; The Montgomery Asberg Depression Rating Scale (MADRS) has been shown to be superior to other clinician-administered instruments, best capturing DSM-IV-TR symptoms of depression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/54\">",
"       54",
"      </a>",
"      ]. It has demonstrated excellent discrimination between depressed and non-depressed individuals [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/55\">",
"       55",
"      </a>",
"      ], and between self-assessed depression and personality disorders [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/56\">",
"       56",
"      </a>",
"      ]. It has also demonstrated good reliability and validity in elderly populations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Generalized anxiety",
"      </strong>",
"      &mdash; The Hamilton Rating Scale for Anxiety (HAMA) is the gold standard measure for the assessment of GAD symptom severity. This scale is reliable and valid, particularly when used with a structured interview guide [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/58\">",
"       58",
"      </a>",
"      ]. The HAMA has demonstrated good ability to discriminate between anxiety and depression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       OCD",
"      </strong>",
"      &mdash; The Yale Brown Obsessive Compulsive Scale (YBOCS) has shown good discrimination between OCD and depression as well as other anxiety disorders in initial validation study, and good sensitivity to change [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/60,61\">",
"       60,61",
"      </a>",
"      ]. The self-report adaptation of the 10-item YBOCS scale and symptom checklist has shown similar reliability patterns [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Panic disorder",
"      </strong>",
"      &mdash; The most commonly used observer-rated scale for panic disorder is the seven-item Panic Disorder Severity Scale (PDSS), which has demonstrated good inter-rater reliability and internal consistency with favorable validity and sensitivity to change when compared to diagnostic interview [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/63,64\">",
"       63,64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       PTSD",
"      </strong>",
"      &mdash; The Clinician Administered PTSD Scale (CAPS) has emerged as the most widely used instrument in clinical trials and has proven to be both an effective assessment tool and severity measure, despite substantial correlation with other measures of depression and anxiety [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite their wide use, the State Trait Anxiety Inventory (STAI) and the Hamilton Rating Scale for Depression (HAMD) have been criticized for an inability to distinguish between anxious and depressive symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/41/38553/abstract/66-69\">",
"     66-69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H537975\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Population-based studies conducted in several countries have shown high rates of co-occurrence between associations between anxiety disorders and mood disorders. Mood disorders have shown the highest correlations with generalized anxiety disorder (GAD) and the lowest with agoraphobia and specific phobias (",
"      <a class=\"graphic graphic_table graphicRef86955 \" href=\"mobipreview.htm?10/29/10718\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H32457357\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Research has found that that patients with co-occurring anxiety and mood disorders were more likely to be female, younger (25 to 34 years), have a lower education level, live alone, be unemployed, have a parental psychiatric history, and to have experienced childhood trauma than those with purely an anxiety or mood disorder. (See",
"      <a class=\"local\" href=\"#H32457378\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While our understanding of the etiology of co-occurring anxiety and depression is limited, research has identified similarities between the two disorders in their neurobiology, genetic structure, and presence of neuroticism and harm avoidance. (See",
"      <a class=\"local\" href=\"#H32457385\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Co-occurring anxiety and depressive disorders have been found to differ from the individual disorder categories in age of onset, life course, and treatment outcome. Presence of both disorders together significantly decreases the odds of recovery, increases the time to therapeutic onset for pharmacotherapy, and is associated with a more chronic course. (See",
"      <a class=\"local\" href=\"#H32457507\">",
"       'Course'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical manifestations of comorbid anxiety and depression are often complex. Both anxiety and depressive disorders present overlapping symptoms including irritability,",
"      <span class=\"nowrap\">",
"       agitation/restlessness,",
"      </span>",
"      difficulties concentrating, insomnia, and fatigue (",
"      <a class=\"graphic graphic_table graphicRef87209 \" href=\"mobipreview.htm?35/34/36395\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H428203\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis of co-occurring depressive and anxiety disorders is based on DSM-IV-TR criteria for the individual disorders. Further research is needed on two proposed disorders, mixed anxiety and depression, and anxious depression, both of which incorporate symptoms of anxiety or depression below thresholds required by individual DSM-IV-TR depressive and anxiety disorders. (See",
"      <a class=\"local\" href=\"#H32457435\">",
"       'Assessment and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/1\">",
"      Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/2\">",
"      Kessler RC, Birnbaum HG, Shahly V, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety 2010; 27:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/3\">",
"      Alonso J, L&eacute;pine JP, ESEMeD/MHEDEA 2000 Scientific Committee. Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). J Clin Psychiatry 2007; 68 Suppl 2:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/4\">",
"      Lamers F, van Oppen P, Comijs HC, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry 2011; 72:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/5\">",
"      de Graaf R, Bijl RV, Smit F, et al. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry 2002; 159:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/6\">",
"      Cyranowski JM, Schott LL, Kravitz HM, et al. Psychosocial features associated with lifetime comorbidity of major depression and anxiety disorders among a community sample of mid-life women: the SWAN mental health study. Depress Anxiety 2012; 29:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/7\">",
"      Sanderson WC, Barlow DH. A description of patients diagnosed with DSM-III-R generalized anxiety disorder. J Nerv Ment Dis 1990; 178:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/8\">",
"      T&uuml;kel R, Meteris H, Koyuncu A, et al. The clinical impact of mood disorder comorbidity on obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 2006; 256:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/9\">",
"      Brown TA, Barlow DH. Comorbidity among anxiety disorders: implications for treatment and DSM-IV. J Consult Clin Psychol 1992; 60:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/10\">",
"      Brown TA, Campbell LA, Lehman CL, et al. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol 2001; 110:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/11\">",
"      Pini S, Cassano GB, Simonini E, et al. Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord 1997; 42:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/12\">",
"      Rodney J, Prior N, Cooper B, et al. The comorbidity of anxiety and depression. Aust N Z J Psychiatry 1997; 31:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/13\">",
"      Fava M, Rankin MA, Wright EC, et al. Anxiety disorders in major depression. Compr Psychiatry 2000; 41:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/14\">",
"      Verhagen M, van der Meij A, Franke B, et al. Familiality of major depressive disorder and patterns of lifetime comorbidity. The NEMESIS and GenMood studies. A comparison of three samples. Eur Arch Psychiatry Clin Neurosci 2008; 258:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/15\">",
"      Wittchen HU, Kessler RC, Pfister H, Lieb M. Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatr Scand Suppl 2000; :14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/16\">",
"      Bittner A, Goodwin RD, Wittchen HU, et al. What characteristics of primary anxiety disorders predict subsequent major depressive disorder? J Clin Psychiatry 2004; 65:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/17\">",
"      Beesdo K, Bittner A, Pine DS, et al. Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Arch Gen Psychiatry 2007; 64:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/18\">",
"      Damsa C, Kosel M, Moussally J. Current status of brain imaging in anxiety disorders. Curr Opin Psychiatry 2009; 22:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/19\">",
"      Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 2007; 164:1476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/20\">",
"      Martin EI, Ressler KJ, Binder E, Nemeroff CB. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin North Am 2009; 32:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/21\">",
"      de Graaf R, Bijl RV, ten Have M, et al. Rapid onset of comorbidity of common mental disorders: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand 2004; 109:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/22\">",
"      Khan AA, Jacobson KC, Gardner CO, et al. Personality and comorbidity of common psychiatric disorders. Br J Psychiatry 2005; 186:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/23\">",
"      Enoch MA, White KV, Waheed J, Goldman D. Neurophysiological and genetic distinctions between pure and comorbid anxiety disorders. Depress Anxiety 2008; 25:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/24\">",
"      Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 2003; 60:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/25\">",
"      Hettema JM, Prescott CA, Myers JM, et al. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 2005; 62:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/26\">",
"      Middeldorp CM, Cath DC, Van Dyck R, Boomsma DI. The co-morbidity of anxiety and depression in the perspective of genetic epidemiology. A review of twin and family studies. Psychol Med 2005; 35:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/27\">",
"      Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991; 100:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/28\">",
"      Clark DA, Beck AT, Beck JS. Symptom differences in major depression, dysthymia, panic disorder, and generalized anxiety disorder. Am J Psychiatry 1994; 151:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/29\">",
"      Barlow DH, DiNardo PA, Vermilyea BB, et al. Co-morbidity and depression among the anxiety disorders. Issues in diagnosis and classification. J Nerv Ment Dis 1986; 174:63.",
"     </a>",
"    </li>",
"    <li>",
"     Kendall PC, Watson D. Anxiety and Depression: distinctive and overlapping features, Academic Press, San Diego, CA 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/31\">",
"      Beesdo K, Pine DS, Lieb R, Wittchen HU. Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry 2010; 67:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/32\">",
"      Bruce SE, Yonkers KA, Otto MW, et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/33\">",
"      Kessler RC, Gruber M, Hettema JM, et al. Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychol Med 2008; 38:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/34\">",
"      Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 2005; 35:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/35\">",
"      Merikangas KR, Zhang H, Avenevoli S, et al. Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch Gen Psychiatry 2003; 60:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/36\">",
"      Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163:1905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/37\">",
"      Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 2008; 165:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/38\">",
"      Stein DJ, Baldwin DS, Baldinetti F, Mandel F. Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies. Eur Neuropsychopharmacol 2008; 18:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/39\">",
"      Overbeek T, Schruers K, Vermetten E, Griez E. Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect. J Clin Psychiatry 2002; 63:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/40\">",
"      Woody S, McLean PD, Taylor S, Koch WJ. Treatment of major depression in the context of panic disorder. J Affect Disord 1999; 53:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/41\">",
"      Rief W, Trenkamp S, Auer C, Fichter MM. Cognitive behavior therapy in panic disorder and comorbid major depression. A naturalistic study. Psychother Psychosom 2000; 69:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/42\">",
"      Ledley DR, Huppert JD, Foa EB, et al. Impact of depressive symptoms on the treatment of generalized social anxiety disorder. Depress Anxiety 2005; 22:161.",
"     </a>",
"    </li>",
"    <li>",
"     America Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th ed, America Psychiatric Association, Washington 1994.",
"    </li>",
"    <li>",
"     World Health Organization. International Classification of Diseases and Related Health Conditions (10th Revision), World Health Organization, Geneva, Switzerland 1992.",
"    </li>",
"    <li>",
"     Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision (DSM-IV-TR), American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/46\">",
"      Wittchen HU, Essau CA. Comorbidity and mixed anxiety-depressive disorders: is there epidemiologic evidence? J Clin Psychiatry 1993; 54 Suppl:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/47\">",
"      Stein MB, Kirk P, Prabhu V, et al. Mixed anxiety-depression in a primary-care clinic. J Affect Disord 1995; 34:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/48\">",
"      Weisberg RB, Maki KM, Culpepper L, Keller MB. Is anyone really M.A.D.?: the occurrence and course of mixed anxiety-depressive disorder in a sample of primary care patients. J Nerv Ment Dis 2005; 193:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/49\">",
"      Means-Christensen AJ, Sherbourne CD, Roy-Byrne PP, et al. In search of mixed anxiety-depressive disorder: a primary care study. Depress Anxiety 2006; 23:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/50\">",
"      Fava M, Alpert JE, Carmin CN, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med 2004; 34:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/51\">",
"      Brown TA, Di Nardo PA, Lehman CL, Campbell LA. Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. J Abnorm Psychol 2001; 110:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/52\">",
"      Wittchen HU, Kessler RC, Beesdo K, et al. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry 2002; 63 Suppl 8:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/53\">",
"      Antony MM, Bieling PJ, Cox BJ, et al. Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychol Assess 1998; 10:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/54\">",
"      Furukawa TA. Assessment of mood: guides for clinicians. J Psychosom Res 2010; 68:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/55\">",
"      Bernstein IH, Rush AJ, Stegman D, et al. A Comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an Adult Outpatient Clinical Sample. CNS Spectr 2010; 15:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/56\">",
"      Svanborg P, Asberg M. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS). J Affect Disord 2001; 64:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/57\">",
"      Mottram P, Wilson K, Copeland J. Validation of the Hamilton Depression Rating Scale and Montgommery and Asberg Rating Scales in terms of AGECAT depression cases. Int J Geriatr Psychiatry 2000; 15:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/58\">",
"      Shear MK, Vander Bilt J, Rucci P, et al. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety 2001; 13:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/59\">",
"      Vaccarino AL, Evans KR, Sills TL, Kalali AH. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression. Depress Anxiety 2008; 25:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/60\">",
"      Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/61\">",
"      Gibb BE, Coles ME, Heimberg RG. Differentiating symptoms of social anxiety and depression in adults with social anxiety disorder. J Behav Ther Exp Psychiatry 2005; 36:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/62\">",
"      Steketee G, Frost R, Bogart K. The Yale-Brown Obsessive Compulsive Scale: interview versus self-report. Behav Res Ther 1996; 34:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/63\">",
"      Shear MK, Brown TA, Barlow DH, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry 1997; 154:1571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/64\">",
"      Shear MK, Rucci P, Williams J, et al. Reliability and validity of the Panic Disorder Severity Scale: replication and extension. J Psychiatr Res 2001; 35:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/65\">",
"      Weathers FW, Keane TM, Davidson JR. Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety 2001; 13:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/66\">",
"      Kennedy BL, Schwab JJ, Morris RL, Beldia G. Assessment of state and trait anxiety in subjects with anxiety and depressive disorders. Psychiatr Q 2001; 72:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/67\">",
"      Creamer M, Foran J, Bell R. The Beck Anxiety Inventory in a non-clinical sample. Behav Res Ther 1995; 33:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/68\">",
"      Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 2004; 161:2163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/41/38553/abstract/69\">",
"      Demyttenaere K, De Fruyt J. Getting what you ask for: on the selectivity of depression rating scales. Psychother Psychosom 2003; 72:61.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14623 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-4F64B2DDF4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38553=[""].join("\n");
var outline_f37_41_38553=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H537975\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32457350\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32457357\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32457364\">",
"      Population-based samples",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32457371\">",
"      Clinical samples",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32457378\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32457385\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32457393\">",
"      Neurobiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32457400\">",
"      Neuropsychological factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32457407\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1127765512\">",
"      Conceptual issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H428203\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32457507\">",
"      COURSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32457414\">",
"      Onset and life course",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32457428\">",
"      Treatment response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32457435\">",
"      ASSESSMENT AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1127765585\">",
"      Co-occurring depression and anxiety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H538333\">",
"      Mixed anxiety and depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H538340\">",
"      Anxious depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H538605\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32457450\">",
"      Diagnostic reliability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32457457\">",
"      Rating scales",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H537975\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/14623\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/14623|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/29/10718\" title=\"table 1\">",
"      Prevalence of comorbid depression in anxiety disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/34/36395\" title=\"table 2\">",
"      Distinctive and overlapping symptoms of depression and anxiety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/54/29547\" title=\"table 3\">",
"      Dx criteria generalized anxiety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/16/10508\" title=\"table 4\">",
"      Physical causes anxiety Sxs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/61/2013\" title=\"table 5\">",
"      Drugs causing anxiety Sxs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/21/17756\" title=\"table 6\">",
"      DSM-IV-TR diagnostic criteria for major depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/4/26700\" title=\"table 7\">",
"      DSM-IV-TR diagnostic criteria for dysthymic disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/1/15387\" title=\"table 8\">",
"      Diagnostic criteria for obsessive-compulsive disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/9/38044\" title=\"table 9\">",
"      Dx criteria panic disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/15/34043\" title=\"table 10\">",
"      DSM-IV-TR criteria for social anxiety disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/55/9085\" title=\"table 11\">",
"      Diagnosis posttraumatic stress disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/54/39787\" title=\"table 12\">",
"      DSM-IV-TR criteria for specific phobia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/41/22171\" title=\"table 13\">",
"      DSM-IV-TR criteria for agoraphobia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/15/10488?source=related_link\">",
"      Agoraphobia in adults: Epidemiology, clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/0/32776?source=related_link\">",
"      Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36564?source=related_link\">",
"      Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44713?source=related_link\">",
"      Panic disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/44/44744?source=related_link\">",
"      Social anxiety disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/38/37481?source=related_link\">",
"      Unipolar depression in adults: Epidemiology, pathogenesis, and neurobiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/19/38201?source=related_link\">",
"      Unipolar depression in adults: Prognosis and course of illness",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_41_38554="Hedgehog pathway";
var content_f37_41_38554=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F76029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F76029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hedgehog signaling pathway in cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 708px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) In the absence of Hh ligand, Ptch1 inhibits surface localization of Smo and protein kinases phosphorylate Gli proteins, leading to an NH-terminal truncated form, which acts as a repressor of Hh target gene expression. Gli3 is the predominant repressor. Sufu also regulates the pathway by binding to Gli, both in the cytoplasm and in the nucleus, to prevent it from activating Hh target genes. Table, summary of genes implicated in cancer and potential treatment using Hh antagonists or Hh antibodies. B) Hh-mediated (Sonic, Indian, or Desert) inactivation of Ptch1 allows relocation of Smo to the tip of cilia, leading to downstream signaling events and the activation of the Gli proteins. Mutations in the pathway (*) or overexpression of the Hh ligand are highlighted (**) in (A) and (B) along with possible avenues of treatment using antibodies or small molecules (red arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Evangelista, M, Tlan, H, de Sauvage, FJ. The hedgehog signaling pathway in cancer. Clin Cancer Res 2006; 12:5924. Copyright &copy;2006 The American Association for Cancer Research.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38554=[""].join("\n");
var outline_f37_41_38554=null;
var title_f37_41_38555="TNM staging muc melanoma HN";
var content_f37_41_38555=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F56221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F56221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    TNM classification of mucosal melanoma of the head and neck",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       Primary tumor (T)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T3",
"      </td>",
"      <td>",
"       Mucosal disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       T4a",
"      </td>",
"      <td>",
"       Moderately advanced disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tumor involving deep soft tissue, cartilage, bone, or overlying skin",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       T4b",
"      </td>",
"      <td>",
"       Very advanced disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       Regional lymph nodes (N)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       NX",
"      </td>",
"      <td>",
"       Regional lymph nodes cannot be assessed",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       No regional lymph node metastases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N1",
"      </td>",
"      <td>",
"       Regional lymph node metastases present",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       Distant metastasis (M)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M0",
"      </td>",
"      <td>",
"       No distant metastasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M1",
"      </td>",
"      <td>",
"       Distant metastasis present",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: cTNM is the clinical classification, pTNM is the pathologic classification.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38555=[""].join("\n");
var outline_f37_41_38555=null;
var title_f37_41_38556="Cardioactive herbal ingredients";
var content_f37_41_38556=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F62487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F62487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cardioactive herbal ingredients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Broom",
"       </td>",
"       <td>",
"        Alkaloid constituents; cardiac depressant activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calamus",
"       </td>",
"       <td>",
"        Antiarrhythmic activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cereus",
"       </td>",
"       <td>",
"        Tyramine; cardiotonic amine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cola",
"       </td>",
"       <td>",
"        Caffeine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coltsfoot",
"       </td>",
"       <td>",
"        Cardiac calcium channel blocking activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Devil's claw",
"       </td>",
"       <td>",
"        Activity in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fenugreek",
"       </td>",
"       <td>",
"        Activity in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Figwort",
"       </td>",
"       <td>",
"        Cardioactive glycoside constituents; activity in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fumitory",
"       </td>",
"       <td>",
"        Alkaloid constituents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ginger",
"       </td>",
"       <td>",
"        Activity in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ginseng, panax",
"       </td>",
"       <td>",
"        Activity in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Golden seal alkaloid",
"       </td>",
"       <td>",
"        Berberine; cardioactive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hawthorn",
"       </td>",
"       <td>",
"        Tyramine; cardiotonic amine; activity in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Horehound, white",
"       </td>",
"       <td>",
"        Activity in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lime flower",
"       </td>",
"       <td>",
"        Activity reputed with excessive ingestion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mat&eacute;",
"       </td>",
"       <td>",
"        Caffeine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mistletoe",
"       </td>",
"       <td>",
"        Viscotoxin; negative inotropic effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Motherwort",
"       </td>",
"       <td>",
"        Cardiac glycoside constituents; activity in vitro",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parsley",
"       </td>",
"       <td>",
"        Apiole poisoning, high doses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pleurisy root",
"       </td>",
"       <td>",
"        Cardenolides, active in vitro and in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prickly ash, nothern",
"       </td>",
"       <td>",
"        Interaction with Na-K-ATPase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prickly ash, southern",
"       </td>",
"       <td>",
"        Interaction with Na-K-ATPase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quassia",
"       </td>",
"       <td>",
"        Activity in vitro",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shepherd's purse",
"       </td>",
"       <td>",
"        Activity in vitro",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Squill",
"       </td>",
"       <td>",
"        Cardiac glycoside constituents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wild carrot",
"       </td>",
"       <td>",
"        Depressant activity in vivo",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. The Pharmaceutical Press 1996, p. 277.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38556=[""].join("\n");
var outline_f37_41_38556=null;
var title_f37_41_38557="Cyclic versus chronic vomiting";
var content_f37_41_38557=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F54863&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F54863&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Differences between cyclic and chronic temporal patterns of vomiting",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 252px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Differences between cyclic and chronic temporal patterns of vomiting can be compared when the number of emeses is plotted over a two-month period. The chronic pattern (red line) is characterized by low-grade, nearly daily episodes whereas the cyclic pattern (black line) is marked by high-intensity episodes every several weeks.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Li BU. New hope for children with cyclic vomiting syndrome. Contemp Pediatr 2002; 19:121.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38557=[""].join("\n");
var outline_f37_41_38557=null;
var title_f37_41_38558="Bronchogenic carcinoma CT I";
var content_f37_41_38558=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F73744&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F73744&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Peripheral bronchogenic carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 276px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows peripheral mass, in the right lung representing a T3 bronchogenic carcinoma, invading and extending through the intercostal space.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38558=[""].join("\n");
var outline_f37_41_38558=null;
var title_f37_41_38559="Shoulder posterior capsule stretch";
var content_f37_41_38559=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1086px;\">",
"  <div class=\"videoplayer\" h264=\"./images/EM/86080/Sh_post_caps_stretch_video.mp4?title=Shoulder+posterior+capsule+stretch\" style=\"width:496px;height:288px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Shoulder posterior capsule stretch",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Stretching of the posterior capsule is performed throughout the rehabilitation of patients with a&nbsp;shoulder impingement syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Craig Parsons, MS, PT and the Physical Therapy Network.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_41_38559=[""].join("\n");
var outline_f37_41_38559=null;
